Send us a Message



Submit Data |  Help |  Video Tutorials |  News |  Publications |  Download |  REST API |  Citing RGD |  Contact   

CHEBI ONTOLOGY - ANNOTATIONS

The Chemical Entities of Biological Interest (ChEBI) ontology is downloaded weekly from EMBL-EBI at http://www.ebi.ac.uk/chebi/. The data is made available under the Creative Commons License (CC BY 3.0, http://creativecommons.org/licenses/by/3.0/). For more information see: Degtyarenko et al. (2008) ChEBI: a database and ontology for chemical entities of biological interest. Nucleic Acids Res. 36, D344–D350.

Term:mancude organic heterotricyclic parent
go back to main search page
Accession:CHEBI:36416 term browser browse the term
Synonyms:related_synonym: mancude organic heterotricyclic parents;   mancude-ring organic heterotricyclic parents



show annotations for term's descendants           Sort by:
1,10-phenanthroline term browser
Symbol Object Name Qualifiers Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
G ACE angiotensin I converting enzyme decreases expression EXP 1,10-phenanthroline results in decreased expression of ACE mRNA CTD PMID:19502547 NCBI chr17:63,477,061...63,498,373
Ensembl chr17:63,477,061...63,498,380
JBrowse link
G AHR aryl hydrocarbon receptor decreases activity
multiple interactions
ISO
EXP
1,10-phenanthroline results in decreased activity of AHR protein
[copper(II) nitrate binds to 1,10-phenanthroline binds to Quinolones] which results in increased activity of AHR protein; resveratrol inhibits the reaction [[copper(II) nitrate binds to 1,10-phenanthroline binds to Quinolones] which results in increased activity of AHR protein]
1,10-phenanthroline inhibits the reaction [Tetrachlorodibenzodioxin binds to AHR protein]; 1,10-phenanthroline inhibits the reaction [Tetrachlorodibenzodioxin promotes the reaction [AHR protein binds to CYP1A1 enhancer]]; Zinc inhibits the reaction [1,10-phenanthroline results in decreased activity of AHR protein]
CTD PMID:1322109 PMID:2160969 PMID:27180721 NCBI chr 7:17,298,652...17,346,147
Ensembl chr 7:16,916,359...17,346,152
JBrowse link
G AK1 adenylate kinase 1 decreases expression EXP 1,10-phenanthroline results in decreased expression of AK1 mRNA CTD PMID:19502547 NCBI chr 9:127,866,480...127,879,621
Ensembl chr 9:127,866,486...127,877,675
JBrowse link
G AKAP9 A-kinase anchoring protein 9 increases expression EXP 1,10-phenanthroline results in increased expression of AKAP9 mRNA CTD PMID:19502547 NCBI chr 7:91,940,862...92,110,673
Ensembl chr 7:91,940,840...92,110,673
JBrowse link
G AKR1C1 aldo-keto reductase family 1 member C1 decreases activity EXP 1,10-phenanthroline results in decreased activity of AKR1C1 protein CTD PMID:8573067 PMID:12604236 NCBI chr10:4,963,415...4,983,283
Ensembl chr10:4,963,253...4,983,283
JBrowse link
G AKR1C2 aldo-keto reductase family 1 member C2 decreases activity EXP 1,10-phenanthroline results in decreased activity of AKR1C2 protein CTD PMID:12604236 NCBI chr10:4,987,775...5,018,000
Ensembl chr10:4,987,775...5,018,031
JBrowse link
G AKR1C3 aldo-keto reductase family 1 member C3 decreases activity EXP 1,10-phenanthroline results in decreased activity of AKR1C3 protein CTD PMID:12604236 NCBI chr10:5,048,781...5,107,686
Ensembl chr10:5,035,354...5,107,686
JBrowse link
G AKR1C4 aldo-keto reductase family 1 member C4 decreases activity EXP 1,10-phenanthroline results in decreased activity of AKR1C4 protein CTD PMID:12604236 NCBI chr10:5,196,837...5,218,949
Ensembl chr10:5,195,462...5,218,949
JBrowse link
G ALDOA aldolase, fructose-bisphosphate A increases expression EXP 1,10-phenanthroline results in increased expression of ALDOA mRNA CTD PMID:19502547 NCBI chr16:30,064,279...30,070,420
Ensembl chr16:30,064,164...30,070,457
JBrowse link
G ALDOC aldolase, fructose-bisphosphate C increases expression EXP 1,10-phenanthroline results in increased expression of ALDOC mRNA CTD PMID:19502547 NCBI chr17:28,573,120...28,576,895
Ensembl chr17:28,573,115...28,576,948
JBrowse link
G ANKRD37 ankyrin repeat domain 37 increases expression EXP 1,10-phenanthroline results in increased expression of ANKRD37 mRNA CTD PMID:19502547 NCBI chr 4:185,396,841...185,400,723
Ensembl chr 4:185,396,021...185,400,628
JBrowse link
G ANPEP alanyl aminopeptidase, membrane decreases activity
multiple interactions
EXP 1,10-phenanthroline results in decreased activity of ANPEP protein
Edetic Acid promotes the reaction [1,10-phenanthroline results in decreased activity of ANPEP protein]
CTD PMID:17109655 NCBI chr15:89,784,895...89,814,852
Ensembl chr15:89,784,895...89,815,401
JBrowse link
G AQP3 aquaporin 3 (Gill blood group) decreases expression EXP 1,10-phenanthroline results in decreased expression of AQP3 mRNA CTD PMID:19641517 NCBI chr 9:33,441,160...33,447,593
Ensembl chr 9:33,441,156...33,447,596
JBrowse link
G ASPA aspartoacylase decreases activity EXP 1,10-phenanthroline results in decreased activity of ASPA protein CTD PMID:17027983 NCBI chr17:3,474,110...3,503,405
Ensembl chr17:3,472,374...3,503,405
JBrowse link
G ATF6 activating transcription factor 6 multiple interactions EXP [1,10-phenanthroline results in decreased activity of MBTPS2 protein] which affects the localization of ATF6 protein; [1,10-phenanthroline results in decreased activity of MBTPS2 protein] which results in decreased cleavage of ATF6 protein CTD PMID:21355074 NCBI chr 1:161,766,320...161,964,070
Ensembl chr 1:161,766,298...161,977,574
JBrowse link
G BNIP3L BCL2 interacting protein 3 like decreases expression EXP 1,10-phenanthroline results in decreased expression of BNIP3L mRNA CTD PMID:19502547 NCBI chr 8:26,383,054...26,413,127
Ensembl chr 8:26,383,054...26,505,636
JBrowse link
G CA9 carbonic anhydrase 9 increases expression EXP 1,10-phenanthroline results in increased expression of CA9 mRNA CTD PMID:19502547 NCBI chr 9:35,673,928...35,681,159
Ensembl chr 9:35,673,928...35,681,159
JBrowse link
G CAT catalase decreases expression EXP 1,10-phenanthroline results in decreased expression of CAT mRNA CTD PMID:19502547 NCBI chr11:34,438,934...34,472,060
Ensembl chr11:34,438,934...34,472,060
JBrowse link
G CD83 CD83 molecule increases expression EXP 1,10-phenanthroline results in increased expression of CD83 mRNA CTD PMID:19641517 NCBI chr 6:14,117,256...14,136,918
Ensembl chr 6:14,117,256...14,136,918
JBrowse link
G CD86 CD86 molecule increases expression
multiple interactions
EXP 1,10-phenanthroline results in increased expression of CD86 mRNA
Acetylcysteine inhibits the reaction [1,10-phenanthroline results in increased expression of CD86 mRNA]; SB 203580 inhibits the reaction [1,10-phenanthroline results in increased expression of CD86 mRNA]
CTD PMID:19641517 NCBI chr 3:122,055,362...122,121,136
Ensembl chr 3:122,055,362...122,121,139
JBrowse link
G CFTR CF transmembrane conductance regulator increases activity EXP 1,10-phenanthroline results in increased activity of CFTR protein CTD PMID:15921678 NCBI chr 7:117,480,025...117,668,665
Ensembl chr 7:117,287,120...117,715,971
JBrowse link
G CXCL8 C-X-C motif chemokine ligand 8 increases expression EXP 1,10-phenanthroline results in increased expression of CXCL8 mRNA CTD PMID:19641517 NCBI chr 4:73,740,569...73,743,716
Ensembl chr 4:73,740,519...73,743,716
JBrowse link
G CYP1A1 cytochrome P450 family 1 subfamily A member 1 multiple interactions
increases stability
ISO
EXP
1,10-phenanthroline inhibits the reaction [Benzo(a)pyrene results in increased expression of CYP1A1 protein]; [1,10-phenanthroline co-treated with cupric chloride] inhibits the reaction [Benzo(a)pyrene results in increased expression of CYP1A1 mRNA]; [1,10-phenanthroline co-treated with cupric chloride] inhibits the reaction [Benzo(a)pyrene results in increased expression of CYP1A1 protein]; ferric chloride inhibits the reaction [1,10-phenanthroline inhibits the reaction [Benzo(a)pyrene results in increased expression of CYP1A1 protein]]; zinc chloride inhibits the reaction [1,10-phenanthroline inhibits the reaction [Benzo(a)pyrene results in increased expression of CYP1A1 protein]]
[copper(II) nitrate binds to 1,10-phenanthroline binds to Quinolones] which results in increased expression of CYP1A1 mRNA
1,10-phenanthroline inhibits the reaction [Tetrachlorodibenzodioxin promotes the reaction [AHR protein binds to CYP1A1 enhancer]]
1,10-phenanthroline results in increased stability of CYP1A1 mRNA
CTD PMID:1322109 PMID:19896525 PMID:27180721 NCBI chr15:74,719,542...74,725,528
Ensembl chr15:74,719,542...74,725,536
JBrowse link
G EGLN1 egl-9 family hypoxia inducible factor 1 increases expression EXP 1,10-phenanthroline results in increased expression of EGLN1 mRNA CTD PMID:19502547 NCBI chr 1:231,363,756...231,422,287
Ensembl chr 1:231,363,751...231,422,287
JBrowse link
G EGLN2 egl-9 family hypoxia inducible factor 2 decreases expression EXP 1,10-phenanthroline results in decreased expression of EGLN2 mRNA CTD PMID:19502547 NCBI chr19:40,799,191...40,808,434
Ensembl chr19:40,798,996...40,808,434
JBrowse link
G EGR1 early growth response 1 increases expression EXP 1,10-phenanthroline results in increased expression of EGR1 mRNA CTD PMID:19502547 NCBI chr 5:138,465,479...138,469,303
Ensembl chr 5:138,465,479...138,469,303
JBrowse link
G ENO1 enolase 1 increases expression EXP 1,10-phenanthroline results in increased expression of ENO1 mRNA CTD PMID:19502547 NCBI chr 1:8,861,000...8,878,686
Ensembl chr 1:8,861,000...8,879,190
JBrowse link
G ENO2 enolase 2 increases expression EXP 1,10-phenanthroline results in increased expression of ENO2 mRNA CTD PMID:19502547 NCBI chr12:6,914,580...6,923,697
Ensembl chr12:6,913,745...6,923,698
JBrowse link
G ERCC2 ERCC excision repair 2, TFIIH core complex helicase subunit decreases expression EXP 1,10-phenanthroline results in decreased expression of ERCC2 mRNA CTD PMID:19502547 NCBI chr19:45,349,837...45,370,573
Ensembl chr19:45,349,837...45,370,918
JBrowse link
G GAPDH glyceraldehyde-3-phosphate dehydrogenase increases expression EXP 1,10-phenanthroline results in increased expression of GAPDH mRNA CTD PMID:19502547 NCBI chr12:6,534,517...6,538,371
Ensembl chr12:6,534,512...6,538,374
JBrowse link
G GPX3 glutathione peroxidase 3 decreases expression EXP 1,10-phenanthroline results in decreased expression of GPX3 mRNA CTD PMID:19502547 NCBI chr 5:151,020,591...151,028,988
Ensembl chr 5:151,020,591...151,028,988
JBrowse link
G H2AX H2A.X variant histone multiple interactions EXP [Copper binds to phthalic acid binds to 1,10-phenanthroline] which results in increased expression of H2AX protein modified form CTD PMID:22659117 NCBI chr11:119,093,874...119,095,465
Ensembl chr11:119,093,874...119,095,465
JBrowse link
G HAMP hepcidin antimicrobial peptide decreases expression EXP 1,10-phenanthroline results in decreased expression of HAMP mRNA CTD PMID:25633564 NCBI chr19:35,282,528...35,285,143
Ensembl chr19:35,280,716...35,285,143
JBrowse link
G HBEGF heparin binding EGF like growth factor increases expression EXP 1,10-phenanthroline results in increased expression of HBEGF mRNA CTD PMID:26800359 NCBI chr 5:140,332,843...140,346,603
Ensembl chr 5:140,332,843...140,346,603
JBrowse link
G HIF1A hypoxia inducible factor 1 subunit alpha multiple interactions
increases activity
EXP
ISO
4'-O-methylalpinumisoflavone inhibits the reaction [1,10-phenanthroline deficiency results in increased activity of HIF1A protein]; alpinumisoflavone inhibits the reaction [1,10-phenanthroline deficiency results in increased activity of HIF1A protein]
HIF1A protein promotes the reaction [1,10-phenanthroline results in increased expression of VEGFA protein]
1,10-phenanthroline results in increased activity of HIF1A protein
CTD PMID:19091749 PMID:19502547 NCBI chr14:61,695,513...61,748,258
Ensembl chr14:61,695,513...61,748,259
JBrowse link
G HIF3A hypoxia inducible factor 3 subunit alpha decreases expression EXP 1,10-phenanthroline results in decreased expression of HIF3A mRNA CTD PMID:19502547 NCBI chr19:46,297,042...46,343,433
Ensembl chr19:46,297,042...46,343,433
JBrowse link
G HILPDA hypoxia inducible lipid droplet associated increases expression EXP 1,10-phenanthroline results in increased expression of HILPDA mRNA CTD PMID:19502547 NCBI chr 7:128,455,878...128,458,418
Ensembl chr 7:128,455,849...128,458,418
JBrowse link
G HK1 hexokinase 1 increases expression EXP 1,10-phenanthroline results in increased expression of HK1 mRNA CTD PMID:19502547 NCBI chr10:69,270,000...69,401,882
Ensembl chr10:69,269,984...69,401,884
JBrowse link
G HK2 hexokinase 2 increases expression EXP 1,10-phenanthroline results in increased expression of HK2 mRNA CTD PMID:19502547 NCBI chr 2:74,834,127...74,893,359
Ensembl chr 2:74,834,127...74,893,359
JBrowse link
G HMOX1 heme oxygenase 1 multiple interactions EXP 1,10-phenanthroline inhibits the reaction [9,10-phenanthrenequinone results in decreased expression of HMOX1 protein]; 1,10-phenanthroline inhibits the reaction [Cadmium Chloride results in increased expression of HMOX1 mRNA]; 1,10-phenanthroline inhibits the reaction [Hydrogen Peroxide results in increased expression of HMOX1 mRNA]; 1,10-phenanthroline inhibits the reaction [Oxygen results in increased expression of HMOX1 mRNA]; 1,10-phenanthroline inhibits the reaction [Raloxifene Hydrochloride results in increased expression of HMOX1 mRNA]; 1,10-phenanthroline inhibits the reaction [sodium arsenite results in increased expression of HMOX1 mRNA] CTD PMID:9747510 PMID:15629867 PMID:20888885 NCBI chr22:35,381,096...35,394,207
Ensembl chr22:35,380,361...35,394,214
JBrowse link
G ICAM1 intercellular adhesion molecule 1 multiple interactions EXP 1,10-phenanthroline affects the reaction [Smoke results in increased expression of ICAM1 protein] CTD PMID:15560890 NCBI chr19:10,271,120...10,286,615
Ensembl chr19:10,271,093...10,286,615
JBrowse link
G IGFBP5 insulin like growth factor binding protein 5 decreases degradation ISO 1,10-phenanthroline results in decreased degradation of IGFBP5 protein CTD PMID:8894652 NCBI chr 2:216,672,105...216,695,549
Ensembl chr 2:216,672,105...216,695,549
JBrowse link
G IL1R1 interleukin 1 receptor type 1 decreases expression EXP 1,10-phenanthroline results in decreased expression of IL1R1 mRNA CTD PMID:19502547 NCBI chr 2:102,070,390...102,179,874
Ensembl chr 2:102,064,544...102,179,874
JBrowse link
G LAMC2 laminin subunit gamma 2 multiple interactions EXP 1,10-phenanthroline inhibits the reaction [Mustard Gas results in increased degradation of LAMC2 protein] CTD PMID:18095945 NCBI chr 1:183,186,264...183,258,968
Ensembl chr 1:183,186,238...183,245,127
JBrowse link
G LDHA lactate dehydrogenase A increases expression EXP 1,10-phenanthroline results in increased expression of LDHA mRNA CTD PMID:19502547 NCBI chr11:18,394,563...18,408,425
Ensembl chr11:18,394,560...18,408,425
JBrowse link
G MBTPS2 membrane bound transcription factor peptidase, site 2 multiple interactions EXP [1,10-phenanthroline results in decreased activity of MBTPS2 protein] which affects the localization of ATF6 protein; [1,10-phenanthroline results in decreased activity of MBTPS2 protein] which affects the localization of SREBF1 protein; [1,10-phenanthroline results in decreased activity of MBTPS2 protein] which results in decreased cleavage of ATF6 protein; [1,10-phenanthroline results in decreased activity of MBTPS2 protein] which results in decreased cleavage of SREBF1 protein CTD PMID:21355074 NCBI chr  X:21,839,617...21,885,423
Ensembl chr  X:21,839,617...21,885,423
JBrowse link
G MDM2 MDM2 proto-oncogene increases expression EXP 1,10-phenanthroline results in increased expression of MDM2 mRNA CTD PMID:19502547 NCBI chr12:68,808,172...68,850,686
Ensembl chr12:68,808,177...68,845,544
JBrowse link
G MIF macrophage migration inhibitory factor increases expression EXP 1,10-phenanthroline results in increased expression of MIF mRNA CTD PMID:19502547 NCBI chr22:23,894,383...23,895,223
Ensembl chr22:23,894,383...23,895,227
JBrowse link
G MMP8 matrix metallopeptidase 8 decreases activity EXP 1,10-phenanthroline results in decreased activity of MMP8 protein CTD PMID:15057751 NCBI chr11:102,711,796...102,724,954
Ensembl chr11:102,711,796...102,727,050
JBrowse link
G MMP9 matrix metallopeptidase 9 multiple interactions ISO 1,10-phenanthroline inhibits the reaction [PLAU protein results in increased activity of MMP9 protein]
1,10-phenanthroline inhibits the reaction [Adenosine Triphosphate results in increased activity of MMP9 protein]
CTD PMID:20177776 PMID:20195827 NCBI chr20:46,008,908...46,016,561
Ensembl chr20:46,008,908...46,016,561
JBrowse link
G NLN neurolysin decreases activity ISO 1,10-phenanthroline decreases activity of Nln protein RGD PMID:7836437 RGD:9831155 NCBI chr 5:65,722,205...65,829,283
Ensembl chr 5:65,722,205...65,871,725
JBrowse link
G NPPB natriuretic peptide B increases expression EXP 1,10-phenanthroline results in increased expression of NPPB mRNA CTD PMID:19502547 NCBI chr 1:11,857,464...11,858,945
Ensembl chr 1:11,857,464...11,858,945
JBrowse link
G NUB1 negative regulator of ubiquitin like proteins 1 increases expression EXP 1,10-phenanthroline results in increased expression of NUB1 mRNA CTD PMID:19502547 NCBI chr 7:151,341,812...151,378,449
Ensembl chr 7:151,341,772...151,378,449
JBrowse link
G OCLN occludin multiple interactions EXP 1,10-phenanthroline inhibits the reaction [Patulin results in increased degradation of OCLN protein] CTD PMID:19013514 NCBI chr 5:69,492,547...69,558,104
Ensembl chr 5:69,492,292...69,558,104
JBrowse link
G P4HA2 prolyl 4-hydroxylase subunit alpha 2 increases expression EXP 1,10-phenanthroline results in increased expression of P4HA2 mRNA CTD PMID:19502547 NCBI chr 5:132,190,147...132,227,853
Ensembl chr 5:132,190,147...132,295,315
JBrowse link
G PDK1 pyruvate dehydrogenase kinase 1 increases expression EXP 1,10-phenanthroline results in increased expression of PDK1 mRNA CTD PMID:19502547 NCBI chr 2:172,555,373...172,724,312
Ensembl chr 2:172,555,373...172,608,669
JBrowse link
G PDK3 pyruvate dehydrogenase kinase 3 increases expression EXP 1,10-phenanthroline results in increased expression of PDK3 mRNA CTD PMID:19502547 NCBI chr  X:24,465,286...24,550,466
Ensembl chr  X:24,465,244...24,550,466
JBrowse link
G PGK1 phosphoglycerate kinase 1 increases expression EXP 1,10-phenanthroline results in increased expression of PGK1 mRNA CTD PMID:19502547 NCBI chr  X:78,104,248...78,129,295
Ensembl chr  X:77,910,739...78,129,295
JBrowse link
G PLAU plasminogen activator, urokinase multiple interactions ISO 1,10-phenanthroline inhibits the reaction [PLAU protein results in increased activity of MMP9 protein] CTD PMID:20177776 NCBI chr10:73,909,164...73,917,494
Ensembl chr10:73,909,177...73,917,496
JBrowse link
G PLOD3 procollagen-lysine,2-oxoglutarate 5-dioxygenase 3 increases expression EXP 1,10-phenanthroline results in increased expression of PLOD3 mRNA CTD PMID:19502547 NCBI chr 7:101,205,984...101,217,581
Ensembl chr 7:101,205,977...101,218,420
JBrowse link
G PPP2R1B protein phosphatase 2 scaffold subunit Abeta decreases expression EXP 1,10-phenanthroline results in decreased expression of PPP2R1B mRNA CTD PMID:19502547 NCBI chr11:111,688,000...111,766,389
Ensembl chr11:111,726,908...111,766,389
JBrowse link
G PSPH phosphoserine phosphatase decreases expression EXP 1,10-phenanthroline results in decreased expression of PSPH mRNA CTD PMID:19502547 NCBI chr 7:56,011,064...56,051,444
Ensembl chr 7:56,011,051...56,051,604
JBrowse link
G SELE selectin E multiple interactions EXP 1,10-phenanthroline affects the reaction [Smoke results in increased expression of SELE protein] CTD PMID:15560890 NCBI chr 1:169,722,640...169,734,079
Ensembl chr 1:169,722,640...169,764,705
JBrowse link
G SERPINE1 serpin family E member 1 increases expression EXP 1,10-phenanthroline results in increased expression of SERPINE1 mRNA CTD PMID:19502547 NCBI chr 7:101,127,104...101,139,247
Ensembl chr 7:101,127,104...101,139,247
JBrowse link
G SOD1 superoxide dismutase 1 multiple interactions EXP 1,10-phenanthroline inhibits the reaction [9,10-phenanthrenequinone results in decreased expression of SOD1 protein]; 1,10-phenanthroline inhibits the reaction [[Hydrogen Peroxide co-treated with Nitroprusside] results in decreased expression of SOD1 protein] CTD PMID:15629867 PMID:20674559 NCBI chr21:31,659,693...31,668,931
Ensembl chr21:31,659,666...31,668,931
JBrowse link
G SOD2 superoxide dismutase 2 multiple interactions EXP 1,10-phenanthroline inhibits the reaction [[Hydrogen Peroxide co-treated with Nitroprusside] results in increased expression of SOD2 protein] CTD PMID:20674559 NCBI chr 6:159,669,069...159,762,281
Ensembl chr 6:159,669,069...159,762,529
JBrowse link
G SREBF1 sterol regulatory element binding transcription factor 1 multiple interactions EXP [1,10-phenanthroline results in decreased activity of MBTPS2 protein] which affects the localization of SREBF1 protein; [1,10-phenanthroline results in decreased activity of MBTPS2 protein] which results in decreased cleavage of SREBF1 protein CTD PMID:21355074 NCBI chr17:17,811,334...17,836,986
Ensembl chr17:17,810,399...17,837,002
JBrowse link
G STAT3 signal transducer and activator of transcription 3 multiple interactions EXP 1,10-phenanthroline inhibits the reaction [Hydrogen Peroxide affects the localization of STAT3 protein] CTD PMID:10364193 NCBI chr17:42,313,324...42,388,442
Ensembl chr17:42,313,324...42,388,568
JBrowse link
G TFRC transferrin receptor increases expression EXP 1,10-phenanthroline results in increased expression of TFRC mRNA CTD PMID:19502547 NCBI chr 3:196,049,284...196,082,090
Ensembl chr 3:196,012,511...196,082,153
JBrowse link
G TIMM17A translocase of inner mitochondrial membrane 17A multiple interactions EXP 1,10-phenanthroline inhibits the reaction [Adenosine Triphosphate results in decreased expression of TIMM17A protein] CTD PMID:24315374 NCBI chr 1:201,955,503...201,970,664
Ensembl chr 1:201,955,503...201,970,664
JBrowse link
G TP53 tumor protein p53 affects folding
affects activity
ISO
EXP
1,10-phenanthroline affects the folding of TRP53 protein
1,10-phenanthroline analog affects the activity of TP53 protein
CTD PMID:8467489 PMID:35435491 NCBI chr17:7,668,421...7,687,490
Ensembl chr17:7,661,779...7,687,538
JBrowse link
G VEGFA vascular endothelial growth factor A increases expression
multiple interactions
EXP
ISO
1,10-phenanthroline results in increased expression of VEGFA mRNA; 1,10-phenanthroline results in increased expression of VEGFA protein
HIF1A protein promotes the reaction [1,10-phenanthroline results in increased expression of VEGFA protein]
CTD PMID:19502547 NCBI chr 6:43,770,211...43,786,487
Ensembl chr 6:43,770,184...43,786,487
JBrowse link
1,7-phenanthroline term browser
Symbol Object Name Qualifiers Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
G AHR aryl hydrocarbon receptor multiple interactions ISO 1,7-phenanthroline inhibits the reaction [Tetrachlorodibenzodioxin binds to AHR protein]; 1,7-phenanthroline inhibits the reaction [Tetrachlorodibenzodioxin promotes the reaction [AHR protein binds to CYP1A1 enhancer]] CTD PMID:1322109 NCBI chr 7:17,298,652...17,346,147
Ensembl chr 7:16,916,359...17,346,152
JBrowse link
G AKR1C1 aldo-keto reductase family 1 member C1 decreases activity EXP 1,7-phenanthroline results in decreased activity of AKR1C1 protein CTD PMID:8573067 NCBI chr10:4,963,415...4,983,283
Ensembl chr10:4,963,253...4,983,283
JBrowse link
G CYP1A1 cytochrome P450 family 1 subfamily A member 1 increases expression
multiple interactions
ISO 1,7-phenanthroline results in increased expression of CYP1A1 protein
1,7-phenanthroline inhibits the reaction [[Dietary Fats co-treated with Dietary Sucrose] results in decreased expression of CYP1A1 protein]; 1,7-phenanthroline inhibits the reaction [Tetrachlorodibenzodioxin promotes the reaction [AHR protein binds to CYP1A1 enhancer]]
CTD PMID:1322109 PMID:17967931 NCBI chr15:74,719,542...74,725,528
Ensembl chr15:74,719,542...74,725,536
JBrowse link
G CYP1A2 cytochrome P450 family 1 subfamily A member 2 multiple interactions
increases expression
ISO 1,7-phenanthroline inhibits the reaction [[Dietary Fats co-treated with Dietary Sucrose] results in decreased expression of CYP1A2 protein]
1,7-phenanthroline results in increased expression of CYP1A2 protein
CTD PMID:17967931 NCBI chr15:74,748,845...74,756,607
Ensembl chr15:74,748,845...74,756,607
JBrowse link
G POU5F1 POU class 5 homeobox 1 decreases expression ISO 1,7-phenanthroline results in decreased expression of POU5F1 protein CTD PMID:21111795 NCBI chr 6:31,164,337...31,170,682
Ensembl chr 6:31,164,337...31,180,731
JBrowse link
G UGT1A6 UDP glucuronosyltransferase family 1 member A6 multiple interactions
increases expression
ISO 1,7-phenanthroline promotes the reaction [[Dietary Fats co-treated with Dietary Sucrose] results in increased expression of UGT1A6 protein]
1,7-phenanthroline results in increased expression of UGT1A6 protein
CTD PMID:17967931 NCBI chr 2:233,691,702...233,773,300
Ensembl chr 2:233,691,607...233,773,300
JBrowse link
10H-phenothiazine term browser
Symbol Object Name Qualifiers Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
G AR androgen receptor affects localization
multiple interactions
EXP phenothiazine analog affects the localization of AR protein
phenothiazine analog binds to and results in decreased activity of AR protein; phenothiazine inhibits the reaction [[6-fluorotestosterone co-treated with Norgestrel] binds to and results in increased activity of AR protein]
CTD PMID:17606915 PMID:33049310 NCBI chr  X:67,544,021...67,730,619
Ensembl chr  X:67,544,021...67,730,619
JBrowse link
G BRD4 bromodomain containing 4 multiple interactions EXP phenothiazine inhibits the reaction [BRD4 protein binds to MED1 protein] CTD PMID:26735014 NCBI chr19:15,235,519...15,332,539
Ensembl chr19:15,235,519...15,332,545
JBrowse link
G ESR1 estrogen receptor 1 multiple interactions EXP phenothiazine binds to and results in increased activity of ESR1 protein CTD PMID:33049310 NCBI chr 6:151,656,672...152,129,619
Ensembl chr 6:151,656,691...152,129,619
JBrowse link
G ESR2 estrogen receptor 2 multiple interactions EXP phenothiazine binds to and results in increased activity of ESR2 protein CTD PMID:33049310 NCBI chr14:64,226,707...64,338,613
Ensembl chr14:64,084,232...64,338,112
JBrowse link
G KCNH2 potassium voltage-gated channel subfamily H member 2 decreases activity EXP phenothiazine results in decreased activity of KCNH2 protein CTD PMID:28551711 NCBI chr 7:150,944,961...150,978,321
Ensembl chr 7:150,944,961...150,978,321
JBrowse link
G KLK3 kallikrein related peptidase 3 multiple interactions EXP phenothiazine analog affects the reaction [Dihydrotestosterone results in increased expression of KLK3 protein] CTD PMID:17606915 NCBI chr19:50,854,915...50,860,764
Ensembl chr19:50,854,915...50,860,764
JBrowse link
G MED1 mediator complex subunit 1 multiple interactions EXP phenothiazine inhibits the reaction [BRD4 protein binds to MED1 protein] CTD PMID:26735014 NCBI chr17:39,404,285...39,451,263
Ensembl chr17:39,404,285...39,451,272
JBrowse link
G NR1I2 nuclear receptor subfamily 1 group I member 2 multiple interactions EXP
ISO
phenothiazine binds to and results in increased activity of NR1I2 protein CTD PMID:33049310 NCBI chr 3:119,782,101...119,818,487
Ensembl chr 3:119,780,484...119,818,487
JBrowse link
G PPARG peroxisome proliferator activated receptor gamma multiple interactions ISO
EXP
phenothiazine binds to and results in increased activity of PPARG protein CTD PMID:33049310 NCBI chr 3:12,287,368...12,434,344
Ensembl chr 3:12,287,368...12,434,356
JBrowse link
1H-imidazo[2,1-i]purine term browser
Symbol Object Name Qualifiers Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
G ALKBH2 alkB homolog 2, alpha-ketoglutarate dependent dioxygenase increases metabolic processing EXP ALKBH2 protein results in increased metabolism of 1,N(6)-ethenoadenine CTD PMID:32293880 NCBI chr12:109,088,189...109,093,472
Ensembl chr12:109,088,188...109,093,631
JBrowse link
G MPG N-methylpurine DNA glycosylase increases metabolic processing EXP MPG protein results in increased metabolism of 1,N(6)-ethenoadenine CTD PMID:10626224 PMID:32293880 NCBI chr16:77,007...85,846
Ensembl chr16:77,007...85,851
JBrowse link
4,7-phenanthroline term browser
Symbol Object Name Qualifiers Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
G AHR aryl hydrocarbon receptor decreases activity
multiple interactions
EXP
ISO
4,7-phenanthroline results in decreased activity of AHR protein
4,7-phenanthroline inhibits the reaction [AHR promotes the reaction [Tetrachlorodibenzodioxin results in decreased uptake of Glucose]]
4,7-phenanthroline inhibits the reaction [Tetrachlorodibenzodioxin binds to AHR protein]; 4,7-phenanthroline inhibits the reaction [Tetrachlorodibenzodioxin promotes the reaction [AHR protein binds to CYP1A1 enhancer]]
CTD PMID:1322109 PMID:8738555 NCBI chr 7:17,298,652...17,346,147
Ensembl chr 7:16,916,359...17,346,152
JBrowse link
G CYP1A1 cytochrome P450 family 1 subfamily A member 1 multiple interactions ISO 4,7-phenanthroline inhibits the reaction [Tetrachlorodibenzodioxin promotes the reaction [AHR protein binds to CYP1A1 enhancer]] CTD PMID:1322109 NCBI chr15:74,719,542...74,725,528
Ensembl chr15:74,719,542...74,725,536
JBrowse link
9H-carbazole term browser
Symbol Object Name Qualifiers Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
G AHR aryl hydrocarbon receptor multiple interactions ISO
EXP
carbazole binds to and results in increased activity of AHR protein CTD PMID:21431309 PMID:28186253 NCBI chr 7:17,298,652...17,346,147
Ensembl chr 7:16,916,359...17,346,152
JBrowse link
acetophenazine term browser
Symbol Object Name Qualifiers Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
G AR androgen receptor multiple interactions EXP acetophenazine binds to and results in decreased activity of AR protein CTD PMID:17606915 NCBI chr  X:67,544,021...67,730,619
Ensembl chr  X:67,544,021...67,730,619
JBrowse link
annomontine term browser
Symbol Object Name Qualifiers Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
G AHR aryl hydrocarbon receptor increases expression EXP annomontine results in increased expression of AHR mRNA CTD PMID:20449727 NCBI chr 7:17,298,652...17,346,147
Ensembl chr 7:16,916,359...17,346,152
JBrowse link
G AHRR aryl hydrocarbon receptor repressor increases expression EXP annomontine results in increased expression of AHRR mRNA CTD PMID:20449727 NCBI chr 5:321,714...438,285
Ensembl chr 5:321,714...438,291
JBrowse link
G CYP1A1 cytochrome P450 family 1 subfamily A member 1 increases expression EXP annomontine results in increased expression of CYP1A1 mRNA CTD PMID:20449727 NCBI chr15:74,719,542...74,725,528
Ensembl chr15:74,719,542...74,725,536
JBrowse link
bathocuproine disulfonic acid term browser
Symbol Object Name Qualifiers Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
G ACTB actin beta multiple interactions EXP [bathocuproine sulfonate co-treated with pyrrolidine dithiocarbamic acid] inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with Ionomycin] results in increased expression of ACTB mRNA] CTD PMID:15477007 NCBI chr 7:5,527,148...5,530,601
Ensembl chr 7:5,526,409...5,563,902
JBrowse link
G ARHGDIA Rho GDP dissociation inhibitor alpha multiple interactions EXP [pyrrolidine dithiocarbamic acid co-treated with bathocuproine sulfonate] results in increased expression of ARHGDIA mRNA CTD PMID:15477007 NCBI chr17:81,867,721...81,871,337
Ensembl chr17:81,867,721...81,871,378
JBrowse link
G ATF4 activating transcription factor 4 multiple interactions EXP [bathocuproine sulfonate co-treated with pyrrolidine dithiocarbamic acid] inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with Ionomycin] results in increased expression of ATF4 mRNA] CTD PMID:15477007 NCBI chr22:39,520,559...39,522,686
Ensembl chr22:39,519,695...39,522,683
JBrowse link
G ATOX1 antioxidant 1 copper chaperone multiple interactions ISO ATOX1 protein affects the reaction [[bathocuproine sulfonate results in decreased abundance of Copper] which results in decreased expression of SLC31A2 mRNA]; ATOX1 protein affects the reaction [[bathocuproine sulfonate results in decreased abundance of Copper] which results in decreased expression of SLC31A2 protein] CTD PMID:20194531 NCBI chr 5:151,742,822...151,758,631
Ensembl chr 5:151,742,316...151,772,532
JBrowse link
G ATP7A ATPase copper transporting alpha multiple interactions EXP [Penicillamine co-treated with bathocuproine sulfonate] promotes the reaction [CLU protein binds to ATP7A protein]; bathocuproine sulfonate inhibits the reaction [ATP7A protein results in increased activity of TYR protein]; cupric chloride inhibits the reaction [bathocuproine sulfonate inhibits the reaction [ATP7A protein results in increased activity of TYR protein]] CTD PMID:11092760 PMID:21242307 NCBI chr  X:77,910,693...78,050,395
Ensembl chr  X:77,910,690...78,050,395
JBrowse link
G ATP7B ATPase copper transporting beta multiple interactions EXP [Penicillamine co-treated with bathocuproine sulfonate] promotes the reaction [CLU protein binds to ATP7B protein] CTD PMID:21242307 NCBI chr13:51,932,669...52,012,132
Ensembl chr13:51,930,436...52,012,125
JBrowse link
G BCL2 BCL2 apoptosis regulator decreases expression EXP bathocuproine sulfonate results in decreased expression of BCL2 protein CTD PMID:24614111 NCBI chr18:63,123,346...63,320,090
Ensembl chr18:63,123,346...63,320,128
JBrowse link
G BCL2A1 BCL2 related protein A1 multiple interactions EXP [bathocuproine sulfonate co-treated with pyrrolidine dithiocarbamic acid] inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with Ionomycin] results in increased expression of BCL2A1 mRNA]; bathocuproine sulfonate inhibits the reaction [pyrrolidine dithiocarbamic acid inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with Ionomycin] results in increased expression of BCL2A1 mRNA]] CTD PMID:15477007 NCBI chr15:79,960,892...79,971,196
Ensembl chr15:79,960,892...79,971,196
JBrowse link
G CASP3 caspase 3 multiple interactions ISO bathocuproine sulfonate inhibits the reaction [[Copper binds to neocuproine] which results in increased activity of CASP3 protein]; bathocuproine sulfonate inhibits the reaction [[Disulfiram binds to cupric chloride] which results in increased activity of CASP3 protein]; bathocuproine sulfonate inhibits the reaction [[pyrrolidine dithiocarbamic acid co-treated with Copper] results in increased activity of CASP3 protein] CTD PMID:10941151 PMID:11239917 PMID:18056745 NCBI chr 4:184,627,696...184,649,447
Ensembl chr 4:184,627,696...184,650,062
JBrowse link
G CASP8 caspase 8 multiple interactions EXP [bathocuproine sulfonate co-treated with pyrrolidine dithiocarbamic acid] inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with Ionomycin] results in decreased expression of CASP8 mRNA]; bathocuproine sulfonate inhibits the reaction [pyrrolidine dithiocarbamic acid inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with Ionomycin] results in decreased expression of CASP8 mRNA]] CTD PMID:15477007 NCBI chr 2:201,233,463...201,287,711
Ensembl chr 2:201,233,443...201,361,836
JBrowse link
G CCL2 C-C motif chemokine ligand 2 multiple interactions EXP bathocuproine sulfonate inhibits the reaction [pyrrolidine dithiocarbamic acid inhibits the reaction [TNF protein results in increased expression of CCL2 mRNA]] CTD PMID:11006087 NCBI chr17:34,255,285...34,257,203
Ensembl chr17:34,255,274...34,257,208
JBrowse link
G CCL3 C-C motif chemokine ligand 3 multiple interactions EXP [bathocuproine sulfonate co-treated with pyrrolidine dithiocarbamic acid] inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with Ionomycin] results in increased expression of CCL3 mRNA] CTD PMID:15477007 NCBI chr17:36,088,256...36,090,143
Ensembl chr17:36,088,256...36,090,169
JBrowse link
G CCL3L1 C-C motif chemokine ligand 3 like 1 multiple interactions EXP [bathocuproine sulfonate co-treated with pyrrolidine dithiocarbamic acid] inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with Ionomycin] results in increased expression of CCL3L1 mRNA] CTD PMID:15477007 Ensembl chr17:36,194,869...36,196,758 JBrowse link
G CCT5 chaperonin containing TCP1 subunit 5 multiple interactions EXP [bathocuproine sulfonate co-treated with pyrrolidine dithiocarbamic acid] inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with Ionomycin] results in increased expression of CCT5 mRNA]; bathocuproine sulfonate inhibits the reaction [pyrrolidine dithiocarbamic acid inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with Ionomycin] results in increased expression of CCT5 mRNA]] CTD PMID:15477007 NCBI chr 5:10,249,921...10,266,412
Ensembl chr 5:10,249,929...10,266,389
JBrowse link
G CD200 CD200 molecule multiple interactions EXP [bathocuproine sulfonate co-treated with pyrrolidine dithiocarbamic acid] inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with Ionomycin] results in increased expression of CD200 mRNA] CTD PMID:15477007 NCBI chr 3:112,332,573...112,362,812
Ensembl chr 3:112,332,347...112,362,812
JBrowse link
G CD44 CD44 molecule (IN blood group) multiple interactions EXP [bathocuproine sulfonate co-treated with pyrrolidine dithiocarbamic acid] inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with Ionomycin] results in increased expression of CD44 mRNA] CTD PMID:15477007 NCBI chr11:35,139,171...35,232,402
Ensembl chr11:35,138,882...35,232,402
JBrowse link
G CDH17 cadherin 17 multiple interactions EXP [bathocuproine sulfonate co-treated with pyrrolidine dithiocarbamic acid] inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with Ionomycin] results in decreased expression of CDH17 mRNA]; [pyrrolidine dithiocarbamic acid co-treated with bathocuproine sulfonate] results in increased expression of CDH17 mRNA CTD PMID:15477007 NCBI chr 8:94,127,162...94,217,278
Ensembl chr 8:94,127,162...94,217,303
JBrowse link
G CLU clusterin multiple interactions EXP [Penicillamine co-treated with bathocuproine sulfonate] promotes the reaction [CLU protein binds to ATP7A protein]; [Penicillamine co-treated with bathocuproine sulfonate] promotes the reaction [CLU protein binds to ATP7B protein] CTD PMID:21242307 NCBI chr 8:27,596,917...27,614,700
Ensembl chr 8:27,596,917...27,614,700
JBrowse link
G CNTNAP1 contactin associated protein 1 multiple interactions EXP [pyrrolidine dithiocarbamic acid co-treated with bathocuproine sulfonate] results in increased expression of CNTNAP1 mRNA CTD PMID:15477007 NCBI chr17:42,682,531...42,699,993
Ensembl chr17:42,682,531...42,699,993
JBrowse link
G COMT catechol-O-methyltransferase multiple interactions EXP [bathocuproine sulfonate co-treated with pyrrolidine dithiocarbamic acid] inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with Ionomycin] results in increased expression of COMT mRNA] CTD PMID:15477007 NCBI chr22:19,941,772...19,969,975
Ensembl chr22:19,941,371...19,969,975
JBrowse link
G CP ceruloplasmin multiple interactions EXP bathocuproine sulfonate inhibits the reaction [pyrrolidine dithiocarbamic acid promotes the reaction [[JUN protein binds to FOS protein] which results in increased expression of and results in increased activity of CP protein]]; bathocuproine sulfonate inhibits the reaction [pyrrolidine dithiocarbamic acid results in increased expression of CP protein] CTD PMID:17032174 NCBI chr 3:149,162,414...149,221,829
Ensembl chr 3:149,162,410...149,221,829
JBrowse link
G CPSF1 cleavage and polyadenylation specific factor 1 multiple interactions EXP [pyrrolidine dithiocarbamic acid co-treated with bathocuproine sulfonate] results in increased expression of CPSF1 mRNA CTD PMID:15477007 NCBI chr 8:144,393,231...144,409,335
Ensembl chr 8:144,393,229...144,409,335
JBrowse link
G CREB1 cAMP responsive element binding protein 1 multiple interactions EXP [pyrrolidine dithiocarbamic acid co-treated with bathocuproine sulfonate] results in increased expression of CREB1 mRNA CTD PMID:15477007 NCBI chr 2:207,529,962...207,605,988
Ensembl chr 2:207,529,737...207,605,988
JBrowse link
G CREM cAMP responsive element modulator multiple interactions EXP [bathocuproine sulfonate co-treated with pyrrolidine dithiocarbamic acid] inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with Ionomycin] results in increased expression of CREM mRNA] CTD PMID:15477007 NCBI chr10:35,126,846...35,212,958
Ensembl chr10:35,126,791...35,212,958
JBrowse link
G CUL5 cullin 5 multiple interactions EXP [bathocuproine sulfonate co-treated with pyrrolidine dithiocarbamic acid] inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with Ionomycin] results in decreased expression of CUL5 mRNA] CTD PMID:15477007 NCBI chr11:108,008,898...108,107,761
Ensembl chr11:108,008,898...108,107,761
JBrowse link
G CYCS cytochrome c, somatic multiple interactions ISO bathocuproine sulfonate inhibits the reaction [[Copper binds to neocuproine] which affects the localization of CYCS protein] CTD PMID:18056745 NCBI chr 7:25,118,656...25,125,260
Ensembl chr 7:25,118,656...25,125,260
JBrowse link
G DNAJB1 DnaJ heat shock protein family (Hsp40) member B1 multiple interactions EXP [pyrrolidine dithiocarbamic acid co-treated with bathocuproine sulfonate] results in increased expression of DNAJB1 mRNA CTD PMID:15477007 NCBI chr19:14,514,769...14,560,391
Ensembl chr19:14,514,769...14,560,391
JBrowse link
G DUSP4 dual specificity phosphatase 4 multiple interactions EXP bathocuproine sulfonate inhibits the reaction [pyrrolidine dithiocarbamic acid inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with Ionomycin] results in increased expression of DUSP4 mRNA]] CTD PMID:15477007 NCBI chr 8:29,333,064...29,350,684
Ensembl chr 8:29,333,064...29,350,684
JBrowse link
G EGR2 early growth response 2 multiple interactions EXP [bathocuproine sulfonate co-treated with pyrrolidine dithiocarbamic acid] inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with Ionomycin] results in increased expression of EGR2 mRNA] CTD PMID:15477007 NCBI chr10:62,811,996...62,819,167
Ensembl chr10:62,811,996...62,819,167
JBrowse link
G EGR3 early growth response 3 multiple interactions EXP [pyrrolidine dithiocarbamic acid co-treated with bathocuproine sulfonate] results in increased expression of EGR3 mRNA CTD PMID:15477007 NCBI chr 8:22,687,659...22,693,480
Ensembl chr 8:22,687,659...22,693,480
JBrowse link
G FASN fatty acid synthase multiple interactions EXP bathocuproine sulfonate inhibits the reaction [copper histidine results in increased expression of FASN mRNA] CTD PMID:24170205 NCBI chr17:82,078,338...82,098,236
Ensembl chr17:82,078,338...82,098,294
JBrowse link
G FGF2 fibroblast growth factor 2 multiple interactions ISO bathocuproine sulfonate inhibits the reaction [FGF2 protein results in increased phosphorylation of MAPK1 protein]; bathocuproine sulfonate inhibits the reaction [FGF2 protein results in increased phosphorylation of MAPK3 protein] CTD PMID:22842628 NCBI chr 4:122,826,682...122,898,236
Ensembl chr 4:122,826,682...122,898,236
JBrowse link
G FOS Fos proto-oncogene, AP-1 transcription factor subunit multiple interactions EXP bathocuproine sulfonate inhibits the reaction [pyrrolidine dithiocarbamic acid inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with Ionomycin] results in increased expression of FOS protein]]; bathocuproine sulfonate inhibits the reaction [pyrrolidine dithiocarbamic acid promotes the reaction [[JUN protein binds to FOS protein] which results in increased expression of and results in increased activity of CP protein]] CTD PMID:15477007 PMID:17032174 NCBI chr14:75,278,828...75,282,230
Ensembl chr14:75,278,826...75,282,230
JBrowse link
G FYB1 FYN binding protein 1 multiple interactions EXP [bathocuproine sulfonate co-treated with pyrrolidine dithiocarbamic acid] inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with Ionomycin] results in decreased expression of FYB1 mRNA] CTD PMID:15477007 NCBI chr 5:39,105,252...39,274,528
Ensembl chr 5:39,105,252...39,274,528
JBrowse link
G GFRA2 GDNF family receptor alpha 2 multiple interactions EXP [bathocuproine sulfonate co-treated with pyrrolidine dithiocarbamic acid] inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with Ionomycin] results in decreased expression of GFRA2 mRNA] CTD PMID:15477007 NCBI chr 8:21,690,398...21,812,345
Ensembl chr 8:21,690,398...21,812,357
JBrowse link
G GNAS GNAS complex locus multiple interactions EXP [pyrrolidine dithiocarbamic acid co-treated with bathocuproine sulfonate] results in increased expression of GNAS mRNA CTD PMID:15477007 NCBI chr20:58,839,748...58,911,192
Ensembl chr20:58,839,718...58,911,192
JBrowse link
G GNLY granulysin multiple interactions EXP [bathocuproine sulfonate co-treated with pyrrolidine dithiocarbamic acid] inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with Ionomycin] results in decreased expression of GNLY mRNA] CTD PMID:15477007 NCBI chr 2:85,694,358...85,698,852
Ensembl chr 2:85,685,175...85,698,852
JBrowse link
G GTF2H2C GTF2H2 family member C multiple interactions EXP [pyrrolidine dithiocarbamic acid co-treated with bathocuproine sulfonate] results in increased expression of GTF2H2C mRNA CTD PMID:15477007 NCBI chr 5:69,560,191...69,595,221
Ensembl chr 5:69,560,191...69,595,221
Ensembl chr 5:69,560,191...69,595,221
JBrowse link
G HADHA hydroxyacyl-CoA dehydrogenase trifunctional multienzyme complex subunit alpha multiple interactions EXP [bathocuproine sulfonate co-treated with pyrrolidine dithiocarbamic acid] inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with Ionomycin] results in increased expression of HADHA mRNA] CTD PMID:15477007 NCBI chr 2:26,190,635...26,244,632
Ensembl chr 2:26,190,635...26,244,672
JBrowse link
G HCK HCK proto-oncogene, Src family tyrosine kinase multiple interactions EXP [bathocuproine sulfonate co-treated with pyrrolidine dithiocarbamic acid] inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with Ionomycin] results in increased expression of HCK mRNA] CTD PMID:15477007 NCBI chr20:32,052,242...32,101,856
Ensembl chr20:32,052,197...32,101,856
JBrowse link
G HMOX1 heme oxygenase 1 multiple interactions EXP [Penicillamine co-treated with bathocuproine sulfonate] results in increased expression of HMOX1 protein CTD PMID:21242307 NCBI chr22:35,381,096...35,394,207
Ensembl chr22:35,380,361...35,394,214
JBrowse link
G HNRNPUL1 heterogeneous nuclear ribonucleoprotein U like 1 multiple interactions EXP [pyrrolidine dithiocarbamic acid co-treated with bathocuproine sulfonate] results in increased expression of HNRNPUL1 mRNA CTD PMID:15477007 NCBI chr19:41,262,557...41,307,787
Ensembl chr19:41,262,496...41,307,787
JBrowse link
G HPX hemopexin multiple interactions ISO bathocuproine sulfonate inhibits the reaction [[cobaltiprotoporphyrin co-treated with HPX protein] affects the localization of MTF1 protein]; bathocuproine sulfonate inhibits the reaction [[cobaltiprotoporphyrin co-treated with HPX protein] results in increased expression of MTF1 mRNA]; bathocuproine sulfonate inhibits the reaction [[Heme co-treated with HPX protein] affects the localization of MTF1 protein] CTD PMID:11213479 NCBI chr11:6,431,049...6,440,987
Ensembl chr11:6,431,049...6,442,617
JBrowse link
G HSPA8 heat shock protein family A (Hsp70) member 8 multiple interactions EXP [pyrrolidine dithiocarbamic acid co-treated with bathocuproine sulfonate] results in increased expression of HSPA8 mRNA; bathocuproine sulfonate inhibits the reaction [pyrrolidine dithiocarbamic acid promotes the reaction [[Tetradecanoylphorbol Acetate co-treated with Ionomycin] results in increased expression of HSPA8 mRNA]] CTD PMID:15477007 NCBI chr11:123,057,489...123,062,462
Ensembl chr11:123,057,489...123,063,230
JBrowse link
G HYAL3 hyaluronidase 3 multiple interactions EXP [pyrrolidine dithiocarbamic acid co-treated with bathocuproine sulfonate] results in increased expression of HYAL3 mRNA CTD PMID:15477007 NCBI chr 3:50,292,832...50,299,405
Ensembl chr 3:50,292,831...50,299,405
JBrowse link
G IL2 interleukin 2 multiple interactions EXP bathocuproine sulfonate inhibits the reaction [pyrrolidine dithiocarbamic acid inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with Ionomycin] results in increased expression of IL2 mRNA]] CTD PMID:15477007 NCBI chr 4:122,451,470...122,456,725
Ensembl chr 4:122,451,470...122,456,725
JBrowse link
G IL2RA interleukin 2 receptor subunit alpha multiple interactions ISO bathocuproine sulfonate inhibits the reaction [di-2-pyridylketone-4,4-dimethyl-3-thiosemicarbazone inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with Ionomycin] results in increased expression of IL2RA protein]] CTD PMID:23134680 NCBI chr10:6,010,689...6,062,367
Ensembl chr10:6,010,689...6,062,370
JBrowse link
G IL2RB interleukin 2 receptor subunit beta multiple interactions EXP [bathocuproine sulfonate co-treated with pyrrolidine dithiocarbamic acid] inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with Ionomycin] results in increased expression of IL2RB mRNA] CTD PMID:15477007 NCBI chr22:37,125,838...37,175,118
Ensembl chr22:37,118,666...37,175,118
JBrowse link
G JUN Jun proto-oncogene, AP-1 transcription factor subunit multiple interactions EXP bathocuproine sulfonate inhibits the reaction [pyrrolidine dithiocarbamic acid promotes the reaction [[JUN protein binds to FOS protein] which results in increased expression of and results in increased activity of CP protein]]; bathocuproine sulfonate inhibits the reaction [pyrrolidine dithiocarbamic acid promotes the reaction [[Tetradecanoylphorbol Acetate co-treated with Ionomycin] results in increased expression of JUN protein]] CTD PMID:15477007 PMID:17032174 NCBI chr 1:58,780,791...58,784,047
Ensembl chr 1:58,776,845...58,784,048
JBrowse link
G LCP1 lymphocyte cytosolic protein 1 multiple interactions EXP [bathocuproine sulfonate co-treated with pyrrolidine dithiocarbamic acid] inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with Ionomycin] results in increased expression of LCP1 mRNA] CTD PMID:15477007 NCBI chr13:46,125,923...46,182,177
Ensembl chr13:46,125,920...46,211,871
JBrowse link
G LDLR low density lipoprotein receptor multiple interactions EXP bathocuproine sulfonate inhibits the reaction [copper histidine results in increased expression of LDLR mRNA] CTD PMID:24170205 NCBI chr19:11,089,463...11,133,820
Ensembl chr19:11,089,418...11,133,820
JBrowse link
G LTBP4 latent transforming growth factor beta binding protein 4 multiple interactions EXP [bathocuproine sulfonate co-treated with pyrrolidine dithiocarbamic acid] inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with Ionomycin] results in decreased expression of LTBP4 mRNA] CTD PMID:15477007 NCBI chr19:40,593,166...40,629,820
Ensembl chr19:40,592,883...40,629,818
JBrowse link
G MAPK1 mitogen-activated protein kinase 1 multiple interactions EXP
ISO
bathocuproine sulfonate inhibits the reaction [pyrrolidine dithiocarbamic acid promotes the reaction [[Tetradecanoylphorbol Acetate co-treated with Ionomycin] results in increased phosphorylation of MAPK1 protein]]
bathocuproine sulfonate inhibits the reaction [FGF2 protein results in increased phosphorylation of MAPK1 protein]
bathocuproine sulfonate inhibits the reaction [pyrrolidine dithiocarbamic acid results in decreased activity of MAPK1 protein]
CTD PMID:10658192 PMID:15477007 PMID:22842628 NCBI chr22:21,759,657...21,867,680
Ensembl chr22:21,759,657...21,867,680
JBrowse link
G MAPK3 mitogen-activated protein kinase 3 multiple interactions EXP
ISO
bathocuproine sulfonate inhibits the reaction [pyrrolidine dithiocarbamic acid promotes the reaction [[Tetradecanoylphorbol Acetate co-treated with Ionomycin] results in increased phosphorylation of MAPK3 protein]]
bathocuproine sulfonate inhibits the reaction [FGF2 protein results in increased phosphorylation of MAPK3 protein]
bathocuproine sulfonate inhibits the reaction [[pyrrolidine dithiocarbamic acid co-treated with Copper] results in increased activity of MAPK3 protein]
CTD PMID:10941151 PMID:15477007 PMID:22842628 NCBI chr16:30,114,105...30,123,220
Ensembl chr16:30,114,105...30,123,506
JBrowse link
G MAPK8 mitogen-activated protein kinase 8 multiple interactions ISO bathocuproine sulfonate inhibits the reaction [[Copper binds to neocuproine] which results in increased activity of MAPK8 protein]; bathocuproine sulfonate inhibits the reaction [[Disulfiram binds to cupric chloride] which results in increased activity of MAPK8 protein]; bathocuproine sulfonate inhibits the reaction [[pyrrolidine dithiocarbamic acid co-treated with Copper] results in increased activity of MAPK8 protein] CTD PMID:10941151 PMID:11239917 PMID:18056745 NCBI chr10:48,306,677...48,439,360
Ensembl chr10:48,306,639...48,439,360
JBrowse link
G MT1B metallothionein 1B multiple interactions EXP [pyrrolidine dithiocarbamic acid co-treated with bathocuproine sulfonate] results in increased expression of MT1B mRNA CTD PMID:15477007 NCBI chr16:56,651,886...56,653,204
Ensembl chr16:56,651,886...56,653,204
JBrowse link
G MT1E metallothionein 1E multiple interactions EXP [pyrrolidine dithiocarbamic acid co-treated with bathocuproine sulfonate] results in increased expression of MT1E mRNA CTD PMID:15477007 NCBI chr16:56,625,781...56,627,112
Ensembl chr16:56,625,475...56,627,112
JBrowse link
G MT1F metallothionein 1F multiple interactions EXP [pyrrolidine dithiocarbamic acid co-treated with bathocuproine sulfonate] results in increased expression of MT1F mRNA CTD PMID:15477007 NCBI chr16:56,657,959...56,659,303
Ensembl chr16:56,657,731...56,660,698
JBrowse link
G MT1G metallothionein 1G multiple interactions EXP [pyrrolidine dithiocarbamic acid co-treated with bathocuproine sulfonate] results in increased expression of MT1G mRNA CTD PMID:15477007 NCBI chr16:56,666,730...56,668,065
Ensembl chr16:56,666,730...56,668,065
JBrowse link
G MT1H metallothionein 1H multiple interactions EXP [pyrrolidine dithiocarbamic acid co-treated with bathocuproine sulfonate] results in increased expression of MT1H mRNA CTD PMID:15477007 NCBI chr16:56,669,814...56,671,129
Ensembl chr16:56,669,814...56,671,129
JBrowse link
G MT1X metallothionein 1X multiple interactions EXP [pyrrolidine dithiocarbamic acid co-treated with bathocuproine sulfonate] results in increased expression of MT1X mRNA CTD PMID:15477007 NCBI chr16:56,682,470...56,684,196
Ensembl chr16:56,682,470...56,684,196
JBrowse link
G MTA1 metastasis associated 1 multiple interactions EXP [pyrrolidine dithiocarbamic acid co-treated with bathocuproine sulfonate] results in increased expression of MTA1 mRNA CTD PMID:15477007 NCBI chr14:105,419,827...105,470,729
Ensembl chr14:105,419,820...105,470,729
JBrowse link
G MTF1 metal regulatory transcription factor 1 multiple interactions ISO bathocuproine sulfonate inhibits the reaction [[cobaltiprotoporphyrin co-treated with HPX protein] affects the localization of MTF1 protein]; bathocuproine sulfonate inhibits the reaction [[cobaltiprotoporphyrin co-treated with HPX protein] results in increased expression of MTF1 mRNA]; bathocuproine sulfonate inhibits the reaction [[Heme co-treated with HPX protein] affects the localization of MTF1 protein] CTD PMID:11213479 NCBI chr 1:37,809,574...37,859,592
Ensembl chr 1:37,809,574...37,859,592
JBrowse link
G MYC MYC proto-oncogene, bHLH transcription factor multiple interactions EXP [bathocuproine sulfonate co-treated with pyrrolidine dithiocarbamic acid] inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with Ionomycin] results in increased expression of MYC mRNA] CTD PMID:15477007 NCBI chr 8:127,735,434...127,742,951
Ensembl chr 8:127,735,434...127,742,951
JBrowse link
G NAA80 N-alpha-acetyltransferase 80, NatH catalytic subunit multiple interactions EXP [bathocuproine sulfonate co-treated with pyrrolidine dithiocarbamic acid] inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with Ionomycin] results in decreased expression of NAA80 mRNA] CTD PMID:15477007 NCBI chr 3:50,296,402...50,299,405
Ensembl chr 3:50,296,402...50,299,416
JBrowse link
G NELL1 neural EGFL like 1 multiple interactions EXP [bathocuproine sulfonate co-treated with pyrrolidine dithiocarbamic acid] inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with Ionomycin] results in increased expression of NELL1 mRNA] CTD PMID:15477007 NCBI chr11:20,669,551...21,575,686
Ensembl chr11:20,669,551...21,575,686
JBrowse link
G NFE2L2 NFE2 like bZIP transcription factor 2 multiple interactions EXP [pyrrolidine dithiocarbamic acid co-treated with bathocuproine sulfonate] results in increased expression of NFE2L2 mRNA CTD PMID:15477007 NCBI chr 2:177,230,303...177,264,727
Ensembl chr 2:177,218,667...177,392,756
JBrowse link
G NFKB1 nuclear factor kappa B subunit 1 multiple interactions EXP bathocuproine sulfonate inhibits the reaction [pyrrolidine dithiocarbamic acid inhibits the reaction [TNF protein results in increased activity of NFKB1 protein]] CTD PMID:11006087 NCBI chr 4:102,501,359...102,617,302
Ensembl chr 4:102,501,330...102,617,302
JBrowse link
G NFKBIA NFKB inhibitor alpha multiple interactions EXP bathocuproine sulfonate inhibits the reaction [pyrrolidine dithiocarbamic acid inhibits the reaction [TNF protein results in increased degradation of NFKBIA protein]] CTD PMID:11006087 NCBI chr14:35,401,513...35,404,749
Ensembl chr14:35,401,079...35,404,749
JBrowse link
G NMI N-myc and STAT interactor multiple interactions EXP [bathocuproine sulfonate co-treated with pyrrolidine dithiocarbamic acid] inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with Ionomycin] results in increased expression of NMI mRNA] CTD PMID:15477007 NCBI chr 2:151,270,470...151,289,668
Ensembl chr 2:151,270,470...151,289,894
JBrowse link
G NR4A3 nuclear receptor subfamily 4 group A member 3 multiple interactions EXP [bathocuproine sulfonate co-treated with pyrrolidine dithiocarbamic acid] inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with Ionomycin] results in increased expression of NR4A3 mRNA] CTD PMID:15477007 NCBI chr 9:99,821,885...99,866,891
Ensembl chr 9:99,821,855...99,866,891
JBrowse link
G ODC1 ornithine decarboxylase 1 multiple interactions EXP [pyrrolidine dithiocarbamic acid co-treated with bathocuproine sulfonate] results in increased expression of ODC1 mRNA CTD PMID:15477007 NCBI chr 2:10,439,968...10,448,327
Ensembl chr 2:10,439,968...10,448,327
JBrowse link
G PAX8 paired box 8 multiple interactions ISO bathocuproine sulfonate inhibits the reaction [pyrrolidine dithiocarbamic acid results in decreased expression of PAX8 mRNA] CTD PMID:11108245 NCBI chr 2:113,215,997...113,278,921
Ensembl chr 2:113,215,997...113,278,921
JBrowse link
G PCNA proliferating cell nuclear antigen decreases expression EXP bathocuproine sulfonate results in decreased expression of PCNA protein CTD PMID:24614111 NCBI chr20:5,114,953...5,126,622
Ensembl chr20:5,114,953...5,126,626
JBrowse link
G PPP1R10 protein phosphatase 1 regulatory subunit 10 multiple interactions EXP [pyrrolidine dithiocarbamic acid co-treated with bathocuproine sulfonate] results in increased expression of PPP1R10 mRNA CTD PMID:15477007 NCBI chr 6:30,600,413...30,617,243
Ensembl chr 6:30,600,413...30,618,612
JBrowse link
G PRNP prion protein (Kanno blood group) multiple interactions ISO bathocuproine sulfonate inhibits the reaction [cupric chloride results in increased expression of PRNP protein] CTD PMID:16148034 NCBI chr20:4,686,456...4,701,588
Ensembl chr20:4,686,350...4,701,590
JBrowse link
G REL REL proto-oncogene, NF-kB subunit multiple interactions EXP [bathocuproine sulfonate co-treated with pyrrolidine dithiocarbamic acid] inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with Ionomycin] results in increased expression of REL mRNA] CTD PMID:15477007 NCBI chr 2:60,881,574...60,931,612
Ensembl chr 2:60,881,491...60,931,612
JBrowse link
G SCO1 synthesis of cytochrome C oxidase 1 increases oxidation EXP bathocuproine sulfonate results in increased oxidation of SCO1 protein CTD PMID:23345593 NCBI chr17:10,672,474...10,697,533
Ensembl chr17:10,672,474...10,698,375
JBrowse link
G SLA Src like adaptor multiple interactions EXP [bathocuproine sulfonate co-treated with pyrrolidine dithiocarbamic acid] inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with Ionomycin] results in increased expression of SLA mRNA] CTD PMID:15477007 NCBI chr 8:133,036,728...133,102,602
Ensembl chr 8:133,036,728...133,102,912
JBrowse link
G SLC31A1 solute carrier family 31 member 1 multiple interactions EXP [bathocuproine sulfonate results in decreased abundance of Copper] which results in increased expression of SLC31A1 mRNA; bathocuproine sulfonate promotes the reaction [SP1 protein results in increased expression of SLC31A1 mRNA] CTD PMID:18483225 NCBI chr 9:113,221,544...113,264,492
Ensembl chr 9:113,221,544...113,264,492
JBrowse link
G SLC31A2 solute carrier family 31 member 2 multiple interactions
affects localization
EXP
ISO
[[bathocuproine sulfonate results in decreased abundance of Copper] which results in decreased expression of SLC31A2 protein] which results in increased uptake of and results in increased susceptibility to Cisplatin; [bathocuproine sulfonate results in decreased abundance of Copper] which results in decreased expression of SLC31A2 protein
bathocuproine sulfonate affects the localization of SLC31A2 protein
ATOX1 protein affects the reaction [[bathocuproine sulfonate results in decreased abundance of Copper] which results in decreased expression of SLC31A2 mRNA]; ATOX1 protein affects the reaction [[bathocuproine sulfonate results in decreased abundance of Copper] which results in decreased expression of SLC31A2 protein]
CTD PMID:20194531 NCBI chr 9:113,151,007...113,164,140
Ensembl chr 9:113,150,976...113,164,140
JBrowse link
G SNRNP70 small nuclear ribonucleoprotein U1 subunit 70 multiple interactions EXP [pyrrolidine dithiocarbamic acid co-treated with bathocuproine sulfonate] results in increased expression of SNRNP70 mRNA CTD PMID:15477007 NCBI chr19:49,085,451...49,108,604
Ensembl chr19:49,085,419...49,108,605
JBrowse link
G SOD1 superoxide dismutase 1 multiple interactions EXP [pyrrolidine dithiocarbamic acid co-treated with bathocuproine sulfonate] results in increased expression of SOD1 mRNA CTD PMID:15477007 NCBI chr21:31,659,693...31,668,931
Ensembl chr21:31,659,666...31,668,931
JBrowse link
G SP1 Sp1 transcription factor multiple interactions EXP bathocuproine sulfonate promotes the reaction [SP1 protein results in increased expression of SLC31A1 mRNA] CTD PMID:18483225 NCBI chr12:53,380,176...53,416,446
Ensembl chr12:53,380,176...53,416,446
JBrowse link
G SRGN serglycin multiple interactions EXP [pyrrolidine dithiocarbamic acid co-treated with bathocuproine sulfonate] results in increased expression of SRGN mRNA CTD PMID:15477007 NCBI chr10:69,087,603...69,104,811
Ensembl chr10:69,088,103...69,104,805
JBrowse link
G SRPRA SRP receptor subunit alpha multiple interactions EXP [bathocuproine sulfonate co-treated with pyrrolidine dithiocarbamic acid] inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with Ionomycin] results in increased expression of SRPRA mRNA] CTD PMID:15477007 NCBI chr11:126,235,930...126,268,895
Ensembl chr11:126,262,938...126,269,144
JBrowse link
G TNF tumor necrosis factor multiple interactions EXP bathocuproine sulfonate inhibits the reaction [pyrrolidine dithiocarbamic acid inhibits the reaction [TNF protein results in increased activity of NFKB1 protein]]; bathocuproine sulfonate inhibits the reaction [pyrrolidine dithiocarbamic acid inhibits the reaction [TNF protein results in increased degradation of NFKBIA protein]]; bathocuproine sulfonate inhibits the reaction [pyrrolidine dithiocarbamic acid inhibits the reaction [TNF protein results in increased expression of CCL2 mRNA]] CTD PMID:11006087 NCBI chr 6:31,575,565...31,578,336
Ensembl chr 6:31,575,565...31,578,336
JBrowse link
G TNFRSF1B TNF receptor superfamily member 1B multiple interactions EXP [bathocuproine sulfonate co-treated with pyrrolidine dithiocarbamic acid] inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with Ionomycin] results in decreased expression of TNFRSF1B mRNA] CTD PMID:15477007 NCBI chr 1:12,166,991...12,209,220
Ensembl chr 1:12,166,991...12,209,228
JBrowse link
G TP53 tumor protein p53 multiple interactions EXP bathocuproine sulfonate inhibits the reaction [[pyrrolidine dithiocarbamic acid results in increased abundance of Copper] which results in increased oxidation of and results in increased expression of TP53 protein] CTD PMID:11964141 NCBI chr17:7,668,421...7,687,490
Ensembl chr17:7,661,779...7,687,538
JBrowse link
G TPO thyroid peroxidase multiple interactions ISO bathocuproine sulfonate inhibits the reaction [pyrrolidine dithiocarbamic acid results in decreased expression of TPO mRNA] CTD PMID:11108245 NCBI chr 2:1,374,047...1,543,673
Ensembl chr 2:1,374,066...1,543,711
JBrowse link
G TRAF1 TNF receptor associated factor 1 multiple interactions EXP [bathocuproine sulfonate co-treated with pyrrolidine dithiocarbamic acid] inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with Ionomycin] results in increased expression of TRAF1 mRNA]; bathocuproine sulfonate inhibits the reaction [pyrrolidine dithiocarbamic acid inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with Ionomycin] results in increased expression of TRAF1 mRNA]] CTD PMID:15477007 NCBI chr 9:120,902,393...120,929,171
Ensembl chr 9:120,902,393...120,929,173
JBrowse link
G TYR tyrosinase multiple interactions EXP bathocuproine sulfonate inhibits the reaction [ATP7A protein results in increased activity of TYR protein]; cupric chloride inhibits the reaction [bathocuproine sulfonate inhibits the reaction [ATP7A protein results in increased activity of TYR protein]] CTD PMID:11092760 NCBI chr11:89,177,875...89,295,759
Ensembl chr11:89,177,875...89,295,759
JBrowse link
G TYROBP transmembrane immune signaling adaptor TYROBP multiple interactions EXP [bathocuproine sulfonate co-treated with pyrrolidine dithiocarbamic acid] inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with Ionomycin] results in decreased expression of TYROBP mRNA] CTD PMID:15477007 NCBI chr19:35,904,403...35,908,295
Ensembl chr19:35,904,401...35,908,295
JBrowse link
G UBE2L6 ubiquitin conjugating enzyme E2 L6 multiple interactions EXP [pyrrolidine dithiocarbamic acid co-treated with bathocuproine sulfonate] results in increased expression of UBE2L6 mRNA CTD PMID:15477007 NCBI chr11:57,551,662...57,567,935
Ensembl chr11:57,551,656...57,568,284
JBrowse link
G UBL4A ubiquitin like 4A multiple interactions EXP [pyrrolidine dithiocarbamic acid co-treated with bathocuproine sulfonate] results in increased expression of UBL4A mRNA CTD PMID:15477007 NCBI chr  X:154,483,717...154,486,615
Ensembl chr  X:154,483,717...154,486,615
JBrowse link
G VIM vimentin multiple interactions EXP [bathocuproine sulfonate co-treated with pyrrolidine dithiocarbamic acid] inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with Ionomycin] results in increased expression of VIM mRNA] CTD PMID:15477007 NCBI chr10:17,228,241...17,237,593
Ensembl chr10:17,228,241...17,237,593
JBrowse link
beta-carboline term browser
Symbol Object Name Qualifiers Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
G AHR aryl hydrocarbon receptor multiple interactions
increases activity
ISO norharman inhibits the reaction [Lipids metabolite results in increased activity of AHR protein]
norharman results in increased activity of AHR protein
CTD PMID:27020609 PMID:28336214 NCBI chr 7:17,298,652...17,346,147
Ensembl chr 7:16,916,359...17,346,152
JBrowse link
G CASP3 caspase 3 increases expression
increases cleavage
EXP norharman results in increased expression of CASP3 mRNA
norharman results in increased cleavage of CASP3 protein
CTD PMID:35985368 NCBI chr 4:184,627,696...184,649,447
Ensembl chr 4:184,627,696...184,650,062
JBrowse link
G CASP7 caspase 7 increases expression EXP norharman results in increased expression of CASP7 mRNA CTD PMID:35985368 NCBI chr10:113,679,194...113,730,909
Ensembl chr10:113,679,162...113,730,907
JBrowse link
G CASP9 caspase 9 increases expression EXP norharman results in increased expression of CASP9 mRNA CTD PMID:35985368 NCBI chr 1:15,491,401...15,524,912
Ensembl chr 1:15,490,832...15,526,534
JBrowse link
G CAT catalase decreases activity EXP norharman results in decreased activity of CAT protein CTD PMID:35985368 NCBI chr11:34,438,934...34,472,060
Ensembl chr11:34,438,934...34,472,060
JBrowse link
G CYP1A1 cytochrome P450 family 1 subfamily A member 1 multiple interactions
increases expression
EXP
ISO
CYP1A1 protein affects the metabolism of [norharman co-treated with aniline]
norharman results in increased expression of CYP1A1 mRNA; norharman results in increased expression of CYP1A1 protein
CTD PMID:15279827 PMID:28336214 NCBI chr15:74,719,542...74,725,528
Ensembl chr15:74,719,542...74,725,536
JBrowse link
G CYP1A2 cytochrome P450 family 1 subfamily A member 2 multiple interactions EXP CYP1A2 protein affects the metabolism of [norharman co-treated with aniline] CTD PMID:15279827 NCBI chr15:74,748,845...74,756,607
Ensembl chr15:74,748,845...74,756,607
JBrowse link
G CYP1B1 cytochrome P450 family 1 subfamily B member 1 multiple interactions EXP CYP1B1 protein affects the metabolism of [norharman co-treated with aniline] CTD PMID:15279827 NCBI chr 2:38,067,509...38,076,151
Ensembl chr 2:38,066,973...38,109,902
JBrowse link
G CYP2B6 cytochrome P450 family 2 subfamily B member 6 multiple interactions EXP CYP2B6 protein affects the metabolism of [norharman co-treated with aniline] CTD PMID:15279827 NCBI chr19:40,991,282...41,018,398
Ensembl chr19:40,991,282...41,018,398
JBrowse link
G CYP2D6 cytochrome P450 family 2 subfamily D member 6 multiple interactions EXP CYP2D6 protein affects the metabolism of [norharman co-treated with aniline] CTD PMID:15279827 NCBI chr22:42,126,499...42,130,810
Ensembl chr22:42,126,499...42,130,865
JBrowse link
G CYP2E1 cytochrome P450 family 2 subfamily E member 1 multiple interactions EXP CYP2E1 protein affects the metabolism of [norharman co-treated with aniline] CTD PMID:15279827 NCBI chr10:133,527,363...133,539,123
Ensembl chr10:133,520,406...133,561,220
JBrowse link
G CYP3A4 cytochrome P450 family 3 subfamily A member 4 multiple interactions EXP CYP3A4 protein affects the metabolism of [norharman co-treated with aniline] CTD PMID:15279827 NCBI chr 7:99,756,967...99,784,184
Ensembl chr 7:99,756,960...99,784,248
JBrowse link
G MAOA monoamine oxidase A decreases activity EXP norharman results in decreased activity of MAOA protein CTD PMID:28057462 NCBI chr  X:43,655,006...43,746,817
Ensembl chr  X:43,654,907...43,746,817
JBrowse link
G MAOB monoamine oxidase B multiple interactions
decreases activity
EXP norharman inhibits the reaction [MAOB protein results in increased oxidation of 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine]
norharman results in decreased activity of MAOB protein
CTD PMID:21554916 NCBI chr  X:43,766,610...43,882,450
Ensembl chr  X:43,766,610...43,882,450
JBrowse link
G NFE2L2 NFE2 like bZIP transcription factor 2 increases expression EXP norharman results in increased expression of NFE2L2 protein CTD PMID:35985368 NCBI chr 2:177,230,303...177,264,727
Ensembl chr 2:177,218,667...177,392,756
JBrowse link
G NQO1 NAD(P)H quinone dehydrogenase 1 increases expression EXP norharman results in increased expression of NQO1 mRNA CTD PMID:35985368 NCBI chr16:69,709,401...69,726,560
Ensembl chr16:69,706,996...69,726,668
JBrowse link
G PARP1 poly(ADP-ribose) polymerase 1 increases cleavage EXP norharman results in increased cleavage of PARP1 protein CTD PMID:35985368 NCBI chr 1:226,360,691...226,408,093
Ensembl chr 1:226,360,210...226,408,154
JBrowse link
G SLC22A1 solute carrier family 22 member 1 multiple interactions
decreases activity
EXP norharman inhibits the reaction [SLC22A1 protein results in increased import of 4-(4-(dimethylamino)styryl)-1-methylpyridinium iodide]
norharman results in decreased activity of SLC22A1 protein
CTD PMID:30189235 NCBI chr 6:160,121,815...160,158,718
Ensembl chr 6:160,121,815...160,158,718
JBrowse link
G SLC22A2 solute carrier family 22 member 2 multiple interactions
decreases activity
EXP norharman inhibits the reaction [SLC22A2 protein results in increased import of 4-(4-(dimethylamino)styryl)-1-methylpyridinium iodide]
norharman results in decreased activity of SLC22A2 protein
CTD PMID:30189235 NCBI chr 6:160,216,755...160,258,821
Ensembl chr 6:160,171,061...160,277,638
JBrowse link
G SLC22A3 solute carrier family 22 member 3 multiple interactions
decreases activity
EXP norharman inhibits the reaction [SLC22A3 protein results in increased import of 4-(4-(dimethylamino)styryl)-1-methylpyridinium iodide]
norharman results in decreased activity of SLC22A3 protein
CTD PMID:30189235 NCBI chr 6:160,348,378...160,452,577
Ensembl chr 6:160,348,378...160,452,577
JBrowse link
G TP53 tumor protein p53 affects activity EXP norharman metabolite affects the activity of TP53 protein CTD PMID:35435491 NCBI chr17:7,668,421...7,687,490
Ensembl chr17:7,661,779...7,687,538
JBrowse link
carbazole term browser
Symbol Object Name Qualifiers Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
G AHR aryl hydrocarbon receptor multiple interactions ISO
EXP
carbazole binds to and results in increased activity of AHR protein CTD PMID:21431309 PMID:28186253 NCBI chr 7:17,298,652...17,346,147
Ensembl chr 7:16,916,359...17,346,152
JBrowse link
clomipramine term browser
Symbol Object Name Qualifiers Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
G AADAT aminoadipate aminotransferase affects expression ISO Clomipramine affects the expression of AADAT mRNA CTD PMID:18355885 NCBI chr 4:170,060,222...170,094,292
Ensembl chr 4:170,060,222...170,091,699
JBrowse link
G ABCB1 ATP binding cassette subfamily B member 1 affects expression ISO Clomipramine affects the expression of ABCB1 mRNA CTD PMID:18355885 NCBI chr 7:87,503,017...87,713,295
Ensembl chr 7:87,503,017...87,713,323
JBrowse link
G ALDH1A1 aldehyde dehydrogenase 1 family member A1 affects expression ISO Clomipramine affects the expression of ALDH1A1 mRNA CTD PMID:18355885 NCBI chr 9:72,900,671...72,953,053
Ensembl chr 9:72,900,671...73,080,442
JBrowse link
G AP1S1 adaptor related protein complex 1 subunit sigma 1 decreases expression EXP Clomipramine results in decreased expression of AP1S1 mRNA CTD PMID:15342952 PMID:17175557 NCBI chr 7:101,154,476...101,161,276
Ensembl chr 7:101,154,456...101,161,596
JBrowse link
G APOA4 apolipoprotein A4 affects expression ISO Clomipramine affects the expression of APOA4 mRNA CTD PMID:18355885 NCBI chr11:116,820,700...116,823,304
Ensembl chr11:116,820,700...116,823,304
JBrowse link
G ASNS asparagine synthetase (glutamine-hydrolyzing) increases expression EXP Clomipramine results in increased expression of ASNS mRNA CTD PMID:17175557 NCBI chr 7:97,851,677...97,928,441
Ensembl chr 7:97,851,677...97,872,542
JBrowse link
G BHMT betaine--homocysteine S-methyltransferase affects expression ISO Clomipramine affects the expression of BHMT mRNA CTD PMID:18355885 NCBI chr 5:79,111,809...79,132,288
Ensembl chr 5:79,111,809...79,132,288
JBrowse link
G CASP3 caspase 3 multiple interactions
increases activity
EXP
ISO
Clomipramine results in increased cleavage of and results in increased activity of CASP3 protein; Palmitic Acid promotes the reaction [Clomipramine results in increased activity of CASP3 protein] CTD PMID:10487422 PMID:22700542 PMID:28482088 NCBI chr 4:184,627,696...184,649,447
Ensembl chr 4:184,627,696...184,650,062
JBrowse link
G CASP7 caspase 7 multiple interactions
increases activity
EXP Palmitic Acid promotes the reaction [Clomipramine results in increased activity of CASP7 protein] CTD PMID:22700542 NCBI chr10:113,679,194...113,730,909
Ensembl chr10:113,679,162...113,730,907
JBrowse link
G CASP8 caspase 8 increases activity ISO Clomipramine results in increased activity of CASP8 protein CTD PMID:28482088 NCBI chr 2:201,233,463...201,287,711
Ensembl chr 2:201,233,443...201,361,836
JBrowse link
G CASP9 caspase 9 increases activity ISO Clomipramine results in increased activity of CASP9 protein CTD PMID:28482088 NCBI chr 1:15,491,401...15,524,912
Ensembl chr 1:15,490,832...15,526,534
JBrowse link
G CAT catalase decreases expression EXP Clomipramine results in decreased expression of CAT protein CTD PMID:1937386 NCBI chr11:34,438,934...34,472,060
Ensembl chr11:34,438,934...34,472,060
JBrowse link
G CDKN2C cyclin dependent kinase inhibitor 2C affects expression ISO Clomipramine affects the expression of CDKN2C mRNA CTD PMID:18355885 NCBI chr 1:50,968,706...50,974,634
Ensembl chr 1:50,960,745...50,974,634
JBrowse link
G CES2 carboxylesterase 2 affects expression ISO Clomipramine affects the expression of CES2 mRNA CTD PMID:18355885 NCBI chr16:66,934,471...66,945,096
Ensembl chr16:66,934,444...66,945,096
JBrowse link
G CMTM6 CKLF like MARVEL transmembrane domain containing 6 affects expression ISO Clomipramine affects the expression of CMTM6 mRNA CTD PMID:18355885 NCBI chr 3:32,481,312...32,502,852
Ensembl chr 3:32,481,312...32,502,852
JBrowse link
G CPPED1 calcineurin like phosphoesterase domain containing 1 affects expression ISO Clomipramine affects the expression of CPPED1 mRNA CTD PMID:18355885 NCBI chr16:12,659,799...12,803,887
Ensembl chr16:12,659,799...12,803,887
JBrowse link
G CREM cAMP responsive element modulator affects expression ISO Clomipramine affects the expression of CREM mRNA CTD PMID:18355885 NCBI chr10:35,126,846...35,212,958
Ensembl chr10:35,126,791...35,212,958
JBrowse link
G CYP1B1 cytochrome P450 family 1 subfamily B member 1 decreases activity EXP Clomipramine results in decreased activity of CYP1B1 protein CTD PMID:33814510 NCBI chr 2:38,067,509...38,076,151
Ensembl chr 2:38,066,973...38,109,902
JBrowse link
G CYP2A13 cytochrome P450 family 2 subfamily A member 13 affects expression ISO Clomipramine affects the expression of CYP2A1 mRNA CTD PMID:18355885 NCBI chr19:41,088,451...41,096,195
Ensembl chr19:41,088,451...41,096,195
JBrowse link
G CYP4F12 cytochrome P450 family 4 subfamily F member 12 affects expression ISO Clomipramine affects the expression of CYP4F2 mRNA CTD PMID:18355885 NCBI chr19:15,673,087...15,697,174
Ensembl chr19:15,673,018...15,697,174
JBrowse link
G DCAF8 DDB1 and CUL4 associated factor 8 affects expression ISO Clomipramine affects the expression of DCAF8 mRNA CTD PMID:18355885 NCBI chr 1:160,215,720...160,262,549
Ensembl chr 1:160,215,715...160,262,549
JBrowse link
G DEPP1 DEPP autophagy regulator 1 increases expression EXP Clomipramine results in increased expression of DEPP1 mRNA CTD PMID:15342952 PMID:17175557 NCBI chr10:44,976,128...44,978,809
Ensembl chr10:44,970,981...44,978,809
JBrowse link
G DRD2 dopamine receptor D2 increases expression ISO Clomipramine results in increased expression of DRD2 protein CTD PMID:20619828 NCBI chr11:113,409,605...113,475,398
Ensembl chr11:113,409,605...113,475,691
JBrowse link
G EIF4B eukaryotic translation initiation factor 4B affects expression ISO Clomipramine affects the expression of EIF4B mRNA CTD PMID:18355885 NCBI chr12:53,006,456...53,042,215
Ensembl chr12:53,006,282...53,042,215
JBrowse link
G EPHX1 epoxide hydrolase 1 affects expression ISO Clomipramine affects the expression of EPHX1 mRNA CTD PMID:18355885 NCBI chr 1:225,810,124...225,845,563
Ensembl chr 1:225,810,124...225,845,563
JBrowse link
G ERP29 endoplasmic reticulum protein 29 affects expression ISO Clomipramine affects the expression of ERP29 mRNA CTD PMID:18355885 NCBI chr12:112,013,426...112,023,449
Ensembl chr12:112,013,348...112,023,449
JBrowse link
G FABP1 fatty acid binding protein 1 increases expression EXP Clomipramine results in increased expression of FABP1 mRNA CTD PMID:15342952 NCBI chr 2:88,122,982...88,128,062
Ensembl chr 2:88,122,982...88,128,062
JBrowse link
G FH fumarate hydratase multiple interactions ISO Clomipramine results in increased activity of and results in increased secretion of FH protein CTD PMID:37217012 NCBI chr 1:241,497,603...241,519,755
Ensembl chr 1:241,497,511...241,519,799
JBrowse link
G FNDC4 fibronectin type III domain containing 4 increases expression
decreases expression
EXP Clomipramine results in increased expression of FNDC4 mRNA
Clomipramine results in decreased expression of FNDC4 mRNA
CTD PMID:17175557 NCBI chr 2:27,491,883...27,495,200
Ensembl chr 2:27,491,883...27,495,200
JBrowse link
G GCKR glucokinase regulator affects expression ISO Clomipramine affects the expression of GCKR mRNA CTD PMID:18355885 NCBI chr 2:27,496,839...27,523,684
Ensembl chr 2:27,496,839...27,523,684
JBrowse link
G GDPD3 glycerophosphodiester phosphodiesterase domain containing 3 increases expression EXP Clomipramine results in increased expression of GDPD3 mRNA CTD PMID:17175557 NCBI chr16:30,104,810...30,113,537
Ensembl chr16:30,104,810...30,113,537
JBrowse link
G GLS2 glutaminase 2 affects expression ISO Clomipramine affects the expression of GLS2 mRNA CTD PMID:18355885 NCBI chr12:56,470,952...56,488,161
Ensembl chr12:56,470,944...56,488,414
JBrowse link
G GOT2 glutamic-oxaloacetic transaminase 2 affects expression ISO Clomipramine affects the expression of GOT2 mRNA CTD PMID:18355885 NCBI chr16:58,707,131...58,734,316
Ensembl chr16:58,707,131...58,734,342
JBrowse link
G GPT glutamic--pyruvic transaminase increases export
multiple interactions
ISO Clomipramine results in increased export of GPT protein
Clomipramine results in increased activity of and results in increased secretion of GPT protein
CTD PMID:37217012 NCBI chr 8:144,503,068...144,507,172
Ensembl chr 8:144,502,973...144,507,174
JBrowse link
G GRB14 growth factor receptor bound protein 14 affects expression ISO Clomipramine affects the expression of GRB14 mRNA CTD PMID:18355885 NCBI chr 2:164,492,417...164,621,482
Ensembl chr 2:164,492,417...164,621,482
JBrowse link
G GSTP1 glutathione S-transferase pi 1 decreases activity EXP Clomipramine results in decreased activity of GSTP1 protein CTD PMID:15094841 NCBI chr11:67,583,812...67,586,653
Ensembl chr11:67,583,742...67,586,656
JBrowse link
G HAL histidine ammonia-lyase affects expression ISO Clomipramine affects the expression of HAL mRNA CTD PMID:18355885 NCBI chr12:95,972,662...95,996,344
Ensembl chr12:95,972,662...95,996,365
JBrowse link
G HMGB2 high mobility group box 2 affects expression ISO Clomipramine affects the expression of HMGB2 mRNA CTD PMID:18355885 NCBI chr 4:173,331,376...173,334,358
Ensembl chr 4:173,331,376...173,334,432
JBrowse link
G HMGCS1 3-hydroxy-3-methylglutaryl-CoA synthase 1 increases expression EXP Clomipramine results in increased expression of HMGCS1 mRNA CTD PMID:16324787 NCBI chr 5:43,287,470...43,313,412
Ensembl chr 5:43,287,470...43,313,512
JBrowse link
G HPN hepsin increases expression EXP Clomipramine results in increased expression of HPN mRNA CTD PMID:15342952 NCBI chr19:35,040,506...35,066,573
Ensembl chr19:35,040,506...35,066,573
JBrowse link
G HTR2C 5-hydroxytryptamine receptor 2C affects binding
increases expression
EXP
ISO
Clomipramine binds to HTR2C protein
Clomipramine results in increased expression of HTR2C protein
CTD PMID:18083778 PMID:20619828 NCBI chr  X:114,584,086...114,910,061
Ensembl chr  X:114,584,078...114,910,061
JBrowse link
G IL1A interleukin 1 alpha multiple interactions EXP [IL6 protein co-treated with IL1A protein co-treated with TNF protein co-treated with lipopolysaccharide, Escherichia coli O111 B4] results in increased susceptibility to Clomipramine CTD PMID:19362101 NCBI chr 2:112,773,925...112,784,493
Ensembl chr 2:112,773,925...112,784,493
JBrowse link
G IL33 interleukin 33 affects expression ISO Clomipramine affects the expression of IL33 mRNA CTD PMID:18355885 NCBI chr 9:6,215,149...6,257,983
Ensembl chr 9:6,215,786...6,257,983
JBrowse link
G IL6 interleukin 6 multiple interactions EXP [IL6 protein co-treated with IL1A protein co-treated with TNF protein co-treated with lipopolysaccharide, Escherichia coli O111 B4] results in increased susceptibility to Clomipramine CTD PMID:19362101 NCBI chr 7:22,727,200...22,731,998
Ensembl chr 7:22,725,884...22,732,002
JBrowse link
G INHBE inhibin subunit beta E increases expression EXP Clomipramine results in increased expression of INHBE mRNA CTD PMID:15342952 PMID:17175557 NCBI chr12:57,455,307...57,458,025
Ensembl chr12:57,452,323...57,459,280
JBrowse link
G KCNH2 potassium voltage-gated channel subfamily H member 2 multiple interactions EXP Clomipramine inhibits the reaction [KCNH2 protein results in increased transport of Thallium] CTD PMID:21158687 NCBI chr 7:150,944,961...150,978,321
Ensembl chr 7:150,944,961...150,978,321
JBrowse link
G LOX lysyl oxidase affects expression ISO Clomipramine affects the expression of LOX mRNA CTD PMID:18355885 NCBI chr 5:122,063,195...122,078,259
Ensembl chr 5:122,063,195...122,078,413
JBrowse link
G LSS lanosterol synthase increases expression EXP Clomipramine results in increased expression of LSS mRNA CTD PMID:15342952 NCBI chr21:46,188,446...46,228,774
Ensembl chr21:46,188,141...46,228,824
JBrowse link
G MACROH2A1 macroH2A.1 histone affects expression ISO Clomipramine affects the expression of MACROH2A1 mRNA CTD PMID:18355885 NCBI chr 5:135,334,381...135,399,887
Ensembl chr 5:135,334,381...135,399,914
JBrowse link
G MANBA mannosidase beta affects expression ISO Clomipramine affects the expression of MANBA mRNA CTD PMID:18355885 NCBI chr 4:102,630,770...102,760,968
Ensembl chr 4:102,630,770...102,760,994
JBrowse link
G MLX MAX dimerization protein MLX affects expression ISO Clomipramine affects the expression of MLX mRNA CTD PMID:18355885 NCBI chr17:42,567,100...42,573,203
Ensembl chr17:42,567,072...42,573,239
JBrowse link
G MRPS18B mitochondrial ribosomal protein S18B affects expression ISO Clomipramine affects the expression of MRPS18B mRNA CTD PMID:18355885 NCBI chr 6:30,617,840...30,626,392
Ensembl chr 6:30,617,840...30,626,395
JBrowse link
G MSMO1 methylsterol monooxygenase 1 affects expression ISO Clomipramine affects the expression of MSMO1 mRNA CTD PMID:18355885 NCBI chr 4:165,327,669...165,343,164
Ensembl chr 4:165,327,667...165,343,164
JBrowse link
G NR0B2 nuclear receptor subfamily 0 group B member 2 increases expression EXP Clomipramine results in increased expression of NR0B2 mRNA CTD PMID:17175557 NCBI chr 1:26,911,489...26,913,975
Ensembl chr 1:26,911,489...26,913,975
JBrowse link
G NREP neuronal regeneration related protein affects expression ISO Clomipramine affects the expression of NREP mRNA CTD PMID:18355885 NCBI chr 5:111,728,802...111,976,932
Ensembl chr 5:111,662,621...111,997,464
JBrowse link
G NTRK2 neurotrophic receptor tyrosine kinase 2 increases phosphorylation ISO Clomipramine results in increased phosphorylation of NTRK2 protein CTD PMID:22396798 NCBI chr 9:84,668,522...85,027,054
Ensembl chr 9:84,668,375...85,095,751
JBrowse link
G NUPR1 nuclear protein 1, transcriptional regulator increases expression EXP Clomipramine results in increased expression of NUPR1 mRNA CTD PMID:15342952 PMID:17175557 NCBI chr16:28,532,708...28,538,974
Ensembl chr16:28,532,708...28,539,008
JBrowse link
G OAF out at first homolog affects expression ISO Clomipramine affects the expression of OAF mRNA CTD PMID:18355885 NCBI chr11:120,211,032...120,230,334
Ensembl chr11:120,211,032...120,230,334
JBrowse link
G PARP1 poly(ADP-ribose) polymerase 1 increases cleavage EXP Clomipramine results in increased cleavage of PARP1 protein CTD PMID:10487422 NCBI chr 1:226,360,691...226,408,093
Ensembl chr 1:226,360,210...226,408,154
JBrowse link
G PC pyruvate carboxylase affects expression ISO Clomipramine affects the expression of PC mRNA CTD PMID:18355885 NCBI chr11:66,848,420...66,958,383
Ensembl chr11:66,848,417...66,958,386
JBrowse link
G PECR peroxisomal trans-2-enoyl-CoA reductase affects expression ISO Clomipramine affects the expression of PECR mRNA CTD PMID:18355885 NCBI chr 2:216,029,088...216,081,809
Ensembl chr 2:215,996,329...216,082,955
JBrowse link
G PHYH phytanoyl-CoA 2-hydroxylase increases expression EXP Clomipramine results in increased expression of PHYH mRNA CTD PMID:15342952 NCBI chr10:13,277,799...13,300,064
Ensembl chr10:13,277,796...13,302,412
JBrowse link
G POR cytochrome p450 oxidoreductase affects expression ISO Clomipramine affects the expression of POR mRNA CTD PMID:18355885 NCBI chr 7:75,915,155...75,986,855
Ensembl chr 7:75,899,200...75,986,855
JBrowse link
G PRL prolactin affects secretion
increases expression
multiple interactions
increases secretion
EXP Clomipramine affects the secretion of PRL protein
Clomipramine results in increased expression of PRL protein
SLC6A4 polymorphism inhibits the reaction [Clomipramine affects the secretion of PRL protein]
Clomipramine results in increased secretion of PRL protein
CTD PMID:3602989 PMID:7930386 PMID:17000009 PMID:19698552 NCBI chr 6:22,287,246...22,302,835
Ensembl chr 6:22,287,244...22,302,826
JBrowse link
G PROC protein C, inactivator of coagulation factors Va and VIIIa increases expression EXP Clomipramine results in increased expression of PROC protein CTD PMID:17891354 NCBI chr 2:127,418,427...127,429,242
Ensembl chr 2:127,418,427...127,429,242
JBrowse link
G RBL2 RB transcriptional corepressor like 2 affects expression ISO Clomipramine affects the expression of RBL2 mRNA CTD PMID:18355885 NCBI chr16:53,434,471...53,491,648
Ensembl chr16:53,433,977...53,491,648
JBrowse link
G SCD stearoyl-CoA desaturase increases expression EXP Clomipramine results in increased expression of SCD mRNA CTD PMID:16324787 NCBI chr10:100,347,233...100,364,826
Ensembl chr10:100,347,233...100,364,826
JBrowse link
G SERPINA3 serpin family A member 3 increases expression EXP Clomipramine results in increased expression of SERPINA3 mRNA CTD PMID:15342952 PMID:17175557 NCBI chr14:94,612,391...94,624,053
Ensembl chr14:94,612,384...94,624,055
JBrowse link
G SH3GL3 SH3 domain containing GRB2 like 3, endophilin A3 affects expression ISO Clomipramine affects the expression of SH3GL3 mRNA CTD PMID:18355885 NCBI chr15:83,447,341...83,633,820
Ensembl chr15:83,447,228...83,618,743
JBrowse link
G SLC22A2 solute carrier family 22 member 2 multiple interactions EXP Clomipramine inhibits the reaction [SLC22A2 protein results in increased uptake of 4-(4-dimethylaminostyryl)-1-methylpyridinium] CTD PMID:21599003 NCBI chr 6:160,216,755...160,258,821
Ensembl chr 6:160,171,061...160,277,638
JBrowse link
G SLC2A3 solute carrier family 2 member 3 decreases expression EXP Clomipramine results in decreased expression of SLC2A3 mRNA CTD PMID:15342952 PMID:17175557 NCBI chr12:7,919,230...7,936,187
Ensembl chr12:7,919,230...8,019,007
JBrowse link
G SLC6A4 solute carrier family 6 member 4 multiple interactions EXP Clomipramine binds to and results in decreased activity of SLC6A4 protein; SLC6A4 polymorphism inhibits the reaction [Clomipramine affects the secretion of PRL protein] CTD PMID:16272152 PMID:17000009 NCBI chr17:30,194,319...30,235,697
Ensembl chr17:30,194,319...30,236,002
JBrowse link
G SLC6A6 solute carrier family 6 member 6 affects expression ISO Clomipramine affects the expression of SLC6A6 mRNA CTD PMID:18355885 NCBI chr 3:14,402,576...14,489,349
Ensembl chr 3:14,402,576...14,489,349
JBrowse link
G SLCO1A2 solute carrier organic anion transporter family member 1A2 affects expression ISO Clomipramine affects the expression of SLCO1A4 mRNA CTD PMID:18355885 NCBI chr12:21,264,600...21,419,634
Ensembl chr12:21,264,600...21,419,594
JBrowse link
G SREBF1 sterol regulatory element binding transcription factor 1 multiple interactions EXP Clomipramine results in increased cleavage of and results in increased activity of SREBF1 protein CTD PMID:16324787 NCBI chr17:17,811,334...17,836,986
Ensembl chr17:17,810,399...17,837,002
JBrowse link
G SREBF2 sterol regulatory element binding transcription factor 2 multiple interactions EXP Clomipramine results in increased cleavage of and results in increased activity of SREBF2 protein CTD PMID:16324787 NCBI chr22:41,833,105...41,907,305
Ensembl chr22:41,833,105...41,907,306
JBrowse link
G ST13 ST13 Hsp70 interacting protein affects expression ISO Clomipramine affects the expression of ST13 mRNA CTD PMID:18355885 NCBI chr22:40,824,535...40,856,639
Ensembl chr22:40,824,535...40,856,639
JBrowse link
G STBD1 starch binding domain 1 affects expression ISO Clomipramine affects the expression of STBD1 mRNA CTD PMID:18355885 NCBI chr 4:76,306,733...76,311,130
Ensembl chr 4:76,306,733...76,311,130
JBrowse link
G STMN1 stathmin 1 affects expression ISO Clomipramine affects the expression of STMN1 mRNA CTD PMID:18355885 NCBI chr 1:25,884,179...25,906,880
Ensembl chr 1:25,884,181...25,906,991
JBrowse link
G TAC1 tachykinin precursor 1 decreases expression ISO Clomipramine results in decreased expression of TAC1 protein CTD PMID:8955926 NCBI chr 7:97,732,086...97,740,472
Ensembl chr 7:97,732,084...97,740,472
JBrowse link
G TAGLN transgelin decreases expression EXP Clomipramine results in decreased expression of TAGLN mRNA CTD PMID:17175557 NCBI chr11:117,199,294...117,207,465
Ensembl chr11:117,199,370...117,207,464
JBrowse link
G TEX261 testis expressed 261 affects expression ISO Clomipramine affects the expression of TEX261 mRNA CTD PMID:18355885 NCBI chr 2:70,985,942...70,994,873
Ensembl chr 2:70,968,325...70,994,873
JBrowse link
G THRA thyroid hormone receptor alpha multiple interactions EXP Clomipramine binds to and results in decreased activity of THRA protein CTD PMID:25752796 NCBI chr17:40,062,193...40,093,867
Ensembl chr17:40,058,290...40,093,867
JBrowse link
G TIMM10B translocase of inner mitochondrial membrane 10B affects expression ISO Clomipramine affects the expression of TIMM10B mRNA CTD PMID:18355885 NCBI chr11:6,481,501...6,484,681
Ensembl chr11:6,481,501...6,484,681
JBrowse link
G TNF tumor necrosis factor multiple interactions EXP [IL6 protein co-treated with IL1A protein co-treated with TNF protein co-treated with lipopolysaccharide, Escherichia coli O111 B4] results in increased susceptibility to Clomipramine CTD PMID:19362101 NCBI chr 6:31,575,565...31,578,336
Ensembl chr 6:31,575,565...31,578,336
JBrowse link
G UBA52 ubiquitin A-52 residue ribosomal protein fusion product 1 affects expression ISO Clomipramine affects the expression of UBA52 mRNA CTD PMID:18355885 NCBI chr19:18,563,766...18,577,550
Ensembl chr19:18,571,730...18,577,550
JBrowse link
G UGT1A1 UDP glucuronosyltransferase family 1 member A1 affects expression ISO Clomipramine affects the expression of UGT1A1 mRNA CTD PMID:18355885 NCBI chr 2:233,760,270...233,773,300
Ensembl chr 2:233,760,270...233,773,300
JBrowse link
G UGT2A1 UDP glucuronosyltransferase family 2 member A1 complex locus affects expression ISO Clomipramine affects the expression of UGT2A1 mRNA CTD PMID:18355885 NCBI chr 4:69,588,417...69,653,247
Ensembl chr 4:69,588,417...69,653,249
JBrowse link
G UGT2B17 UDP glucuronosyltransferase family 2 member B17 affects expression ISO Clomipramine affects the expression of UGT2B1 mRNA CTD PMID:18355885 NCBI chr 4:68,537,173...68,576,322
Ensembl chr 4:68,537,173...68,576,413
JBrowse link
G WIPI1 WD repeat domain, phosphoinositide interacting 1 increases expression EXP Clomipramine results in increased expression of WIPI1 mRNA CTD PMID:15342952 PMID:17175557 NCBI chr17:68,421,281...68,457,496
Ensembl chr17:68,420,948...68,457,513
JBrowse link
dibenzofuran term browser
Symbol Object Name Qualifiers Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
G ACKR3 atypical chemokine receptor 3 increases expression ISO dibenzofuran analog results in increased expression of ACKR3 mRNA CTD PMID:20566336 NCBI chr 2:236,537,122...236,582,354
Ensembl chr 2:236,567,787...236,582,354
JBrowse link
G ADH7 alcohol dehydrogenase 7 (class IV), mu or sigma polypeptide increases expression ISO dibenzofuran analog results in increased expression of ADH7 mRNA CTD PMID:20566336 NCBI chr 4:99,412,263...99,435,342
Ensembl chr 4:99,412,261...99,435,510
JBrowse link
G AHR aryl hydrocarbon receptor multiple interactions
increases activity
affects localization
ISO
EXP
AHR protein promotes the reaction [dibenzofuran analog results in increased expression of CDKN1A mRNA]; AHR protein promotes the reaction [dibenzofuran analog results in increased expression of CDKN1B mRNA]; AHR protein promotes the reaction [dibenzofuran analog results in increased expression of GSTA2 mRNA]; AHR protein promotes the reaction [dibenzofuran analog results in increased expression of PLA2G2A mRNA]; AHR protein promotes the reaction [dibenzofuran analog results in increased expression of PTGS2 mRNA]; dibenzofuran binds to and results in increased activity of AHR protein
dibenzofuran analog results in increased activity of AHR protein
dibenzofuran analog affects the localization of AHR protein
CTD PMID:20566336 PMID:21431309 PMID:28186253 PMID:28669845 NCBI chr 7:17,298,652...17,346,147
Ensembl chr 7:16,916,359...17,346,152
JBrowse link
G AHRR aryl hydrocarbon receptor repressor increases expression ISO dibenzofuran analog results in increased expression of AHRR mRNA CTD PMID:20566336 NCBI chr 5:321,714...438,285
Ensembl chr 5:321,714...438,291
JBrowse link
G ALDH3A1 aldehyde dehydrogenase 3 family member A1 increases expression ISO dibenzofuran analog results in increased expression of ALDH3A1 mRNA CTD PMID:20566336 NCBI chr17:19,737,984...19,748,298
Ensembl chr17:19,737,984...19,748,943
JBrowse link
G ALDH3A2 aldehyde dehydrogenase 3 family member A2 increases expression ISO dibenzofuran analog results in increased expression of ALDH3A2 mRNA CTD PMID:20566336 NCBI chr17:19,648,136...19,677,596
Ensembl chr17:19,648,136...19,685,760
JBrowse link
G AURKB aurora kinase B decreases expression ISO dibenzofuran analog results in decreased expression of AURKB mRNA CTD PMID:20566336 NCBI chr17:8,204,731...8,210,575
Ensembl chr17:8,204,733...8,210,600
JBrowse link
G BARD1 BRCA1 associated RING domain 1 decreases expression ISO dibenzofuran analog results in decreased expression of BARD1 mRNA CTD PMID:20566336 NCBI chr 2:214,725,646...214,809,683
Ensembl chr 2:214,725,646...214,809,683
JBrowse link
G BRCA1 BRCA1 DNA repair associated decreases expression ISO dibenzofuran analog results in decreased expression of BRCA1 mRNA CTD PMID:20566336 NCBI chr17:43,044,295...43,170,327
Ensembl chr17:43,044,295...43,170,245
JBrowse link
G BRCA2 BRCA2 DNA repair associated decreases expression ISO dibenzofuran analog results in decreased expression of BRCA2 mRNA CTD PMID:20566336 NCBI chr13:32,315,508...32,400,268
Ensembl chr13:32,315,086...32,400,268
JBrowse link
G CCL20 C-C motif chemokine ligand 20 increases expression ISO dibenzofuran analog results in increased expression of CCL20 mRNA CTD PMID:20566336 NCBI chr 2:227,813,842...227,817,556
Ensembl chr 2:227,805,739...227,817,564
JBrowse link
G CCNA2 cyclin A2 decreases expression ISO dibenzofuran analog results in decreased expression of CCNA2 mRNA CTD PMID:20566336 NCBI chr 4:121,816,444...121,823,883
Ensembl chr 4:121,816,444...121,823,883
JBrowse link
G CCNB1 cyclin B1 decreases expression ISO dibenzofuran analog results in decreased expression of CCNB1 mRNA CTD PMID:20566336 NCBI chr 5:69,167,150...69,178,245
Ensembl chr 5:69,167,135...69,178,245
JBrowse link
G CDKN1A cyclin dependent kinase inhibitor 1A increases expression
multiple interactions
ISO dibenzofuran analog results in increased expression of CDKN1A mRNA
AHR protein promotes the reaction [dibenzofuran analog results in increased expression of CDKN1A mRNA]
CTD PMID:20566336 NCBI chr 6:36,676,463...36,687,332
Ensembl chr 6:36,676,460...36,687,337
JBrowse link
G CDKN1B cyclin dependent kinase inhibitor 1B increases expression
multiple interactions
ISO dibenzofuran analog results in increased expression of CDKN1B mRNA; dibenzofuran analog results in increased expression of CDKN1B protein
AHR protein promotes the reaction [dibenzofuran analog results in increased expression of CDKN1B mRNA]
CTD PMID:20566336 NCBI chr12:12,717,368...12,722,369
Ensembl chr12:12,685,498...12,722,369
JBrowse link
G CNR1 cannabinoid receptor 1 multiple interactions ISO dibenzofuran analog inhibits the reaction [3-(2-hydroxy-4-(1,1-dimethylheptyl)phenyl)-4-(3-hydroxypropyl)cyclohexanol binds to CNR1 protein] CTD PMID:21880487 NCBI chr 6:88,139,864...88,167,349
Ensembl chr 6:88,139,864...88,166,347
JBrowse link
G CNR2 cannabinoid receptor 2 multiple interactions ISO
EXP
dibenzofuran analog inhibits the reaction [3-(2-hydroxy-4-(1,1-dimethylheptyl)phenyl)-4-(3-hydroxypropyl)cyclohexanol binds to CNR2 protein] CTD PMID:21880487 NCBI chr 1:23,870,515...23,913,362
Ensembl chr 1:23,870,515...23,913,362
JBrowse link
G COX4I2 cytochrome c oxidase subunit 4I2 decreases expression ISO dibenzofuran analog results in decreased expression of COX4I2 mRNA CTD PMID:20566336 NCBI chr20:31,637,912...31,645,006
Ensembl chr20:31,637,912...31,645,006
JBrowse link
G CYP1A1 cytochrome P450 family 1 subfamily A member 1 multiple interactions
increases expression
ISO 2,2',4,4',5-brominated diphenyl ether inhibits the reaction [dibenzofuran analog results in increased expression of CYP1A1 mRNA]; 2,2',4,4'-tetrabromodiphenyl ether inhibits the reaction [dibenzofuran analog results in increased expression of CYP1A1 mRNA]; 2,2',4,4'-tetrabromodiphenyl ether inhibits the reaction [dibenzofuran analog results in increased expression of CYP1A1 protein]
dibenzofuran analog results in increased expression of CYP1A1 mRNA; dibenzofuran analog results in increased expression of CYP1A1 protein
CTD PMID:20566336 NCBI chr15:74,719,542...74,725,528
Ensembl chr15:74,719,542...74,725,536
JBrowse link
G CYP1A2 cytochrome P450 family 1 subfamily A member 2 increases activity
multiple interactions
ISO
EXP
dibenzofuran results in increased activity of CYP1A2 protein
dibenzofuran metabolite results in increased activity of CYP1A2 protein
[acenaphthylene co-treated with acenaphthene co-treated with dibenzofuran co-treated with fluorene co-treated with phenanthrene co-treated with anthracene] results in increased expression of CYP1A2 mRNA
CTD PMID:7750161 PMID:8001243 PMID:26032510 NCBI chr15:74,748,845...74,756,607
Ensembl chr15:74,748,845...74,756,607
JBrowse link
G CYP2F1 cytochrome P450 family 2 subfamily F member 1 increases expression ISO dibenzofuran analog results in increased expression of CYP2F4 mRNA CTD PMID:20566336 NCBI chr19:41,114,432...41,128,381
Ensembl chr19:41,114,432...41,128,381
JBrowse link
G ENTPD1 ectonucleoside triphosphate diphosphohydrolase 1 increases expression ISO dibenzofuran analog results in increased expression of ENTPD1 mRNA CTD PMID:20566336 NCBI chr10:95,694,186...95,877,266
Ensembl chr10:95,711,779...95,877,266
JBrowse link
G GSTA2 glutathione S-transferase alpha 2 multiple interactions
increases expression
ISO AHR protein promotes the reaction [dibenzofuran analog results in increased expression of GSTA2 mRNA] CTD PMID:20566336 NCBI chr 6:52,750,087...52,763,475
Ensembl chr 6:52,750,087...52,763,475
JBrowse link
G JUN Jun proto-oncogene, AP-1 transcription factor subunit increases expression ISO dibenzofuran analog results in increased expression of JUN mRNA CTD PMID:20566336 NCBI chr 1:58,780,791...58,784,047
Ensembl chr 1:58,776,845...58,784,048
JBrowse link
G MAP1LC3B microtubule associated protein 1 light chain 3 beta affects localization
increases expression
EXP dibenzofuran affects the localization of MAP1LC3B protein
dibenzofuran results in increased expression of MAP1LC3B protein modified form
CTD PMID:22173198 NCBI chr16:87,392,336...87,404,774
Ensembl chr16:87,383,953...87,404,779
JBrowse link
G NPTXR neuronal pentraxin receptor increases expression ISO dibenzofuran analog results in increased expression of NPTXR mRNA CTD PMID:20566336 NCBI chr22:38,818,452...38,844,028
Ensembl chr22:38,818,452...38,844,028
JBrowse link
G NQO1 NAD(P)H quinone dehydrogenase 1 increases expression ISO dibenzofuran analog results in increased expression of NQO1 mRNA CTD PMID:20566336 NCBI chr16:69,709,401...69,726,560
Ensembl chr16:69,706,996...69,726,668
JBrowse link
G NR1D2 nuclear receptor subfamily 1 group D member 2 increases expression ISO dibenzofuran analog results in increased expression of NR1D2 mRNA CTD PMID:20566336 NCBI chr 3:23,945,286...23,980,617
Ensembl chr 3:23,945,286...23,980,617
JBrowse link
G PLA2G2A phospholipase A2 group IIA multiple interactions
increases expression
ISO AHR protein promotes the reaction [dibenzofuran analog results in increased expression of PLA2G2A mRNA] CTD PMID:20566336 NCBI chr 1:19,975,431...19,980,434
Ensembl chr 1:19,975,431...19,980,416
JBrowse link
G PTGES prostaglandin E synthase increases expression ISO dibenzofuran analog results in increased expression of PTGES mRNA CTD PMID:20566336 NCBI chr 9:129,738,349...129,753,042
Ensembl chr 9:129,738,331...129,753,042
JBrowse link
G PTGS2 prostaglandin-endoperoxide synthase 2 increases expression
multiple interactions
ISO dibenzofuran analog results in increased expression of PTGS2 mRNA
AHR protein promotes the reaction [dibenzofuran analog results in increased expression of PTGS2 mRNA]
CTD PMID:20566336 NCBI chr 1:186,671,791...186,680,423
Ensembl chr 1:186,671,791...186,680,922
JBrowse link
G RAD51 RAD51 recombinase decreases expression ISO dibenzofuran analog results in decreased expression of RAD51 mRNA CTD PMID:20566336 NCBI chr15:40,694,733...40,732,340
Ensembl chr15:40,694,774...40,732,340
JBrowse link
G RBP4 retinol binding protein 4 increases expression ISO dibenzofuran analog results in increased expression of RBP4 mRNA CTD PMID:20566336 NCBI chr10:93,591,694...93,601,744
Ensembl chr10:93,591,687...93,601,744
JBrowse link
G SERPINE1 serpin family E member 1 increases expression ISO dibenzofuran analog results in increased expression of SERPINE1 mRNA CTD PMID:20566336 NCBI chr 7:101,127,104...101,139,247
Ensembl chr 7:101,127,104...101,139,247
JBrowse link
G SIM2 SIM bHLH transcription factor 2 increases expression ISO dibenzofuran analog results in increased expression of SIM2 mRNA CTD PMID:20566336 NCBI chr21:36,699,115...36,749,917
Ensembl chr21:36,699,115...36,749,917
JBrowse link
G SQSTM1 sequestosome 1 decreases expression EXP dibenzofuran results in decreased expression of SQSTM1 protein CTD PMID:22173198 NCBI chr 5:179,806,393...179,838,078
Ensembl chr 5:179,806,398...179,838,078
JBrowse link
G TIPARP TCDD inducible poly(ADP-ribose) polymerase increases expression ISO dibenzofuran analog results in increased expression of TIPARP mRNA CTD PMID:20566336 NCBI chr 3:156,674,590...156,706,770
Ensembl chr 3:156,673,235...156,706,770
JBrowse link
G TMEM150A transmembrane protein 150A increases expression ISO dibenzofuran analog results in increased expression of TMEM150A mRNA CTD PMID:20566336 NCBI chr 2:85,598,547...85,602,698
Ensembl chr 2:85,598,547...85,603,196
JBrowse link
G TOP2A DNA topoisomerase II alpha decreases expression ISO dibenzofuran analog results in decreased expression of TOP2A mRNA CTD PMID:20566336 NCBI chr17:40,388,525...40,417,896
Ensembl chr17:40,388,525...40,417,896
JBrowse link
dibenzothiophene term browser
Symbol Object Name Qualifiers Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
G AHR aryl hydrocarbon receptor multiple interactions ISO dibenzothiophene binds to and results in increased activity of AHR protein CTD PMID:21431309 NCBI chr 7:17,298,652...17,346,147
Ensembl chr 7:16,916,359...17,346,152
JBrowse link
G ESR1 estrogen receptor 1 increases expression EXP dibenzothiophene results in increased expression of ESR1 mRNA CTD PMID:33314207 NCBI chr 6:151,656,672...152,129,619
Ensembl chr 6:151,656,691...152,129,619
JBrowse link
G HSD3B1 hydroxy-delta-5-steroid dehydrogenase, 3 beta- and steroid delta-isomerase 1 increases expression EXP dibenzothiophene results in increased expression of HSD3B1 mRNA CTD PMID:33314207 NCBI chr 1:119,507,203...119,515,058
Ensembl chr 1:119,507,198...119,515,054
JBrowse link
G PROK1 prokineticin 1 increases expression EXP dibenzothiophene results in increased expression of PROK1 mRNA CTD PMID:33314207 NCBI chr 1:110,451,149...110,457,358
Ensembl chr 1:110,451,149...110,457,358
JBrowse link
ethidium term browser
Symbol Object Name Qualifiers Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
G BCL2 BCL2 apoptosis regulator multiple interactions EXP Ethidium inhibits the reaction [Estradiol results in increased expression of BCL2 mRNA] CTD PMID:15897899 NCBI chr18:63,123,346...63,320,090
Ensembl chr18:63,123,346...63,320,128
JBrowse link
G CCND1 cyclin D1 multiple interactions EXP Ethidium inhibits the reaction [Estradiol results in increased expression of CCND1 mRNA] CTD PMID:15897899 NCBI chr11:69,641,156...69,654,474
Ensembl chr11:69,641,156...69,654,474
JBrowse link
G CCNE1 cyclin E1 multiple interactions EXP Ethidium inhibits the reaction [Estradiol results in increased expression of CCNE1 mRNA] CTD PMID:15897899 NCBI chr19:29,811,991...29,824,312
Ensembl chr19:29,811,991...29,824,312
JBrowse link
G CCNE2 cyclin E2 multiple interactions EXP Ethidium inhibits the reaction [Estradiol results in increased expression of CCNE2 mRNA] CTD PMID:15897899 NCBI chr 8:94,880,224...94,896,693
Ensembl chr 8:94,879,770...94,896,678
JBrowse link
G CD59 CD59 molecule (CD59 blood group) increases mutagenesis EXP Ethidium results in increased mutagenesis of CD59 protein CTD PMID:17045307 NCBI chr11:33,703,010...33,736,479
Ensembl chr11:33,703,010...33,736,479
JBrowse link
G ERO1A endoplasmic reticulum oxidoreductase 1 alpha multiple interactions ISO [Pyruvic Acid co-treated with Uridine co-treated with Ethidium] inhibits the reaction [Rotenone inhibits the reaction [arsenite results in increased expression of ERO1A protein]] CTD PMID:37659621 NCBI chr14:52,639,915...52,695,558
Ensembl chr14:52,639,915...52,695,900
JBrowse link
G GJA1 gap junction protein alpha 1 increases uptake ISO GJA1 protein results in increased uptake of Ethidium CTD PMID:26926986 NCBI chr 6:121,435,646...121,449,727
Ensembl chr 6:121,435,595...121,449,727
JBrowse link
G IL1A interleukin 1 alpha multiple interactions ISO Ethidium inhibits the reaction [sodium arsenate results in increased expression of IL1A protein]; Ethidium inhibits the reaction [tributyltin results in increased expression of IL1A protein] CTD PMID:8875956 PMID:10571731 NCBI chr 2:112,773,925...112,784,493
Ensembl chr 2:112,773,925...112,784,493
JBrowse link
G MT-CO1 mitochondrially encoded cytochrome c oxidase I decreases expression EXP Ethidium results in decreased expression of COX1 protein CTD PMID:18823003 NCBI chr MT:5,904...7,445
Ensembl chr MT:5,904...7,445
JBrowse link
G MT-CO2 mitochondrially encoded cytochrome c oxidase II decreases expression EXP Ethidium results in decreased expression of COX2 mRNA CTD PMID:22712077 NCBI chr MT:7,586...8,269
Ensembl chr MT:7,586...8,269
JBrowse link
G MT-CYB mitochondrially encoded cytochrome b decreases expression EXP Ethidium results in decreased expression of CYTB mRNA CTD PMID:22712077 NCBI chr MT:14,747...15,887
Ensembl chr MT:14,747...15,887
JBrowse link
G MT-ND1 mitochondrially encoded NADH:ubiquinone oxidoreductase core subunit 1 decreases expression EXP Ethidium results in decreased expression of ND1 mRNA CTD PMID:22712077 NCBI chr MT:3,307...4,262
Ensembl chr MT:3,307...4,262
JBrowse link
G MT-ND4 mitochondrially encoded NADH:ubiquinone oxidoreductase core subunit 4 decreases expression EXP Ethidium results in decreased expression of ND4 mRNA CTD PMID:22712077 NCBI chr MT:10,760...12,137
Ensembl chr MT:10,760...12,137
JBrowse link
G NRF1 nuclear respiratory factor 1 increases expression EXP Ethidium results in increased expression of NRF1 mRNA CTD PMID:22712077 NCBI chr 7:129,611,720...129,757,076
Ensembl chr 7:129,611,720...129,757,082
JBrowse link
G P2RX7 purinergic receptor P2X 7 decreases transport
increases transport
EXP P2RX7 gene polymorphism results in decreased transport of Ethidium
P2RX7 protein results in increased transport of Ethidium
CTD PMID:16263709 NCBI chr12:121,132,876...121,188,032
Ensembl chr12:121,132,819...121,188,032
JBrowse link
G RELA RELA proto-oncogene, NF-kB subunit multiple interactions ISO Ethidium inhibits the reaction [cyanoginosin LR results in increased phosphorylation of RELA protein] CTD PMID:35032610 NCBI chr11:65,653,601...65,663,857
Ensembl chr11:65,653,599...65,663,090
JBrowse link
G SLC22A1 solute carrier family 22 member 1 multiple interactions
affects uptake
increases uptake
EXP
ISO
1-Methyl-4-phenylpyridinium inhibits the reaction [SLC22A1 protein results in increased uptake of Ethidium]; Cimetidine inhibits the reaction [SLC22A1 protein results in increased uptake of Ethidium]; Quinine inhibits the reaction [SLC22A1 protein results in increased uptake of Ethidium]; Tetraethylammonium inhibits the reaction [SLC22A1 protein results in increased uptake of Ethidium]
SLC22A1 protein affects the uptake of Ethidium
CTD PMID:19357179 NCBI chr 6:160,121,815...160,158,718
Ensembl chr 6:160,121,815...160,158,718
JBrowse link
G SLC22A2 solute carrier family 22 member 2 increases uptake
multiple interactions
affects uptake
EXP
ISO
SLC22A2 protein results in increased uptake of Ethidium
1-Methyl-4-phenylpyridinium inhibits the reaction [SLC22A2 protein results in increased uptake of Ethidium]; Cimetidine inhibits the reaction [SLC22A2 protein results in increased uptake of Ethidium]; Ethidium inhibits the reaction [SLC22A2 protein results in increased uptake of 1-Methyl-4-phenylpyridinium]; Quinine inhibits the reaction [SLC22A2 protein results in increased uptake of Ethidium]; Tetraethylammonium inhibits the reaction [SLC22A2 protein results in increased uptake of Ethidium]
SLC22A2 protein affects the uptake of Ethidium
CTD PMID:19357179 NCBI chr 6:160,216,755...160,258,821
Ensembl chr 6:160,171,061...160,277,638
JBrowse link
G SLC22A3 solute carrier family 22 member 3 increases uptake
multiple interactions
EXP SLC22A3 protein results in increased uptake of Ethidium
1-Methyl-4-phenylpyridinium inhibits the reaction [SLC22A3 protein results in increased uptake of Ethidium]; Cimetidine inhibits the reaction [SLC22A3 protein results in increased uptake of Ethidium]; Quinine inhibits the reaction [SLC22A3 protein results in increased uptake of Ethidium]; Tetraethylammonium inhibits the reaction [SLC22A3 protein results in increased uptake of Ethidium]
CTD PMID:19357179 NCBI chr 6:160,348,378...160,452,577
Ensembl chr 6:160,348,378...160,452,577
JBrowse link
G STING1 stimulator of interferon response cGAMP interactor 1 multiple interactions ISO Ethidium inhibits the reaction [cyanoginosin LR results in increased expression of STING1 protein] CTD PMID:35032610 NCBI chr 5:139,475,533...139,482,758
Ensembl chr 5:139,475,533...139,482,935
JBrowse link
G TFAM transcription factor A, mitochondrial increases expression EXP Ethidium results in increased expression of TFAM mRNA CTD PMID:22712077 NCBI chr10:58,385,410...58,399,220
Ensembl chr10:58,385,345...58,399,220
JBrowse link
G TNF tumor necrosis factor multiple interactions ISO Ethidium inhibits the reaction [cyanoginosin LR results in increased expression of TNF mRNA] CTD PMID:35032610 NCBI chr 6:31,575,565...31,578,336
Ensembl chr 6:31,575,565...31,578,336
JBrowse link
G TP53 tumor protein p53 affects activity EXP Ethidium affects the activity of TP53 protein CTD PMID:35435491 NCBI chr17:7,668,421...7,687,490
Ensembl chr17:7,661,779...7,687,538
JBrowse link
fluphenazine term browser
Symbol Object Name Qualifiers Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
G ALAD aminolevulinate dehydratase multiple interactions
decreases activity
ISO [Fluphenazine co-treated with diphenyldiselenide] results in decreased activity of ALAD protein
Fluphenazine results in decreased activity of ALAD protein
CTD PMID:19486337 NCBI chr 9:113,386,312...113,401,284
Ensembl chr 9:113,386,312...113,401,290
JBrowse link
G AR androgen receptor multiple interactions EXP Fluphenazine binds to and results in decreased activity of AR protein CTD PMID:17606915 NCBI chr  X:67,544,021...67,730,619
Ensembl chr  X:67,544,021...67,730,619
JBrowse link
G CAT catalase multiple interactions
increases activity
ISO diphenyldiselenide inhibits the reaction [Fluphenazine results in increased activity of CAT protein] CTD PMID:19486337 NCBI chr11:34,438,934...34,472,060
Ensembl chr11:34,438,934...34,472,060
JBrowse link
G CYP2A6 cytochrome P450 family 2 subfamily A member 6 decreases activity EXP Fluphenazine results in decreased activity of CYP2A6 protein CTD PMID:15135088 NCBI chr19:40,843,541...40,850,447
Ensembl chr19:40,843,541...40,850,447
JBrowse link
G CYP2C19 cytochrome P450 family 2 subfamily C member 19 decreases activity EXP Fluphenazine results in decreased activity of CYP2C19 protein CTD PMID:15135088 NCBI chr10:94,762,681...94,855,547
Ensembl chr10:94,762,681...94,855,547
JBrowse link
G CYP2C9 cytochrome P450 family 2 subfamily C member 9 decreases activity EXP Fluphenazine results in decreased activity of CYP2C9 protein CTD PMID:15135088 NCBI chr10:94,938,658...94,990,091
Ensembl chr10:94,938,658...94,990,091
JBrowse link
G CYP2E1 cytochrome P450 family 2 subfamily E member 1 decreases activity EXP Fluphenazine results in decreased activity of CYP2E1 protein CTD PMID:15135088 NCBI chr10:133,527,363...133,539,123
Ensembl chr10:133,520,406...133,561,220
JBrowse link
G CYP3A4 cytochrome P450 family 3 subfamily A member 4 decreases activity EXP Fluphenazine results in decreased activity of CYP3A4 protein CTD PMID:15135088 NCBI chr 7:99,756,967...99,784,184
Ensembl chr 7:99,756,960...99,784,248
JBrowse link
G DRD2 dopamine receptor D2 affects binding EXP Fluphenazine binds to DRD2 protein CTD PMID:17606915 NCBI chr11:113,409,605...113,475,398
Ensembl chr11:113,409,605...113,475,691
JBrowse link
G HTR2A 5-hydroxytryptamine receptor 2A affects binding EXP Fluphenazine binds to HTR2A protein CTD PMID:17606915 NCBI chr13:46,831,546...46,898,082
Ensembl chr13:46,831,546...46,897,076
JBrowse link
G HTR2C 5-hydroxytryptamine receptor 2C affects binding EXP Fluphenazine binds to HTR2C protein CTD PMID:17606915 NCBI chr  X:114,584,086...114,910,061
Ensembl chr  X:114,584,078...114,910,061
JBrowse link
G NGF nerve growth factor multiple interactions ISO Fluphenazine inhibits the reaction [NGF protein results in increased uptake of Calcium] CTD PMID:1374475 NCBI chr 1:115,285,917...115,338,249
Ensembl chr 1:115,285,904...115,338,770
JBrowse link
G PRL prolactin increases secretion EXP Fluphenazine results in increased secretion of PRL protein CTD PMID:9989566 NCBI chr 6:22,287,246...22,302,835
Ensembl chr 6:22,287,244...22,302,826
JBrowse link
G SLC22A2 solute carrier family 22 member 2 multiple interactions EXP Fluphenazine inhibits the reaction [SLC22A2 protein results in increased uptake of 4-(4-dimethylaminostyryl)-1-methylpyridinium] CTD PMID:21599003 NCBI chr 6:160,216,755...160,258,821
Ensembl chr 6:160,171,061...160,277,638
JBrowse link
G TAC1 tachykinin precursor 1 decreases expression EXP Fluphenazine results in decreased expression of TAC1 mRNA CTD PMID:15845098 NCBI chr 7:97,732,086...97,740,472
Ensembl chr 7:97,732,084...97,740,472
JBrowse link
G TFEB transcription factor EB affects localization EXP Fluphenazine affects the localization of TFEB protein CTD PMID:28366621 NCBI chr 6:41,683,978...41,736,223
Ensembl chr 6:41,683,978...41,736,259
JBrowse link
G TMPRSS2 transmembrane serine protease 2 increases expression ISO Fluphenazine results in increased expression of TMPRSS2 mRNA CTD PMID:32808185 NCBI chr21:41,529,791...41,531,118
Ensembl chr21:41,464,300...41,531,116
JBrowse link
G TMPRSS2 transmembrane serine protease 2 increases expression EXP Fluphenazine results in increased expression of TMPRSS2 mRNA CTD PMID:32808185 NCBI chr21:41,464,305...41,508,158
Ensembl chr21:41,464,300...41,531,116
JBrowse link
harmol term browser
Symbol Object Name Qualifiers Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
G AHR aryl hydrocarbon receptor multiple interactions ISO harmol inhibits the reaction [Tetrachlorodibenzodioxin binds to AHR protein] CTD PMID:22001777 NCBI chr 7:17,298,652...17,346,147
Ensembl chr 7:16,916,359...17,346,152
JBrowse link
G CYP1A1 cytochrome P450 family 1 subfamily A member 1 decreases stability
multiple interactions
decreases activity
EXP
ISO
harmol results in decreased stability of CYP1A1 protein
benzyloxycarbonylleucyl-leucyl-leucine aldehyde inhibits the reaction [harmol results in decreased stability of CYP1A1 protein]; harmol inhibits the reaction [Tetrachlorodibenzodioxin results in increased expression of CYP1A1 mRNA]; harmol inhibits the reaction [Tetrachlorodibenzodioxin results in increased expression of CYP1A1 protein]
harmol results in decreased activity of CYP1A1 protein
CTD PMID:22001777 NCBI chr15:74,719,542...74,725,528
Ensembl chr15:74,719,542...74,725,536
JBrowse link
G SULT1A1 sulfotransferase family 1A member 1 multiple interactions EXP
ISO
Mefenamic Acid inhibits the reaction [SULT1A1 protein results in increased sulfation of harmol] CTD PMID:11181495 NCBI chr16:28,605,258...28,623,375
Ensembl chr16:28,605,196...28,610,044
JBrowse link
G SULT1A3 sulfotransferase family 1A member 3 increases sulfation EXP SULT1A3 protein results in increased sulfation of harmol CTD PMID:11181495 NCBI chr16:30,199,255...30,204,310
Ensembl chr16:30,199,228...30,204,310
JBrowse link
imipramine term browser
Symbol Object Name Qualifiers Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
G AADAT aminoadipate aminotransferase affects expression ISO Imipramine affects the expression of AADAT mRNA CTD PMID:18355885 NCBI chr 4:170,060,222...170,094,292
Ensembl chr 4:170,060,222...170,091,699
JBrowse link
G ABCB1 ATP binding cassette subfamily B member 1 affects expression ISO Imipramine affects the expression of ABCB1 mRNA CTD PMID:18355885 NCBI chr 7:87,503,017...87,713,295
Ensembl chr 7:87,503,017...87,713,323
JBrowse link
G ACE2 angiotensin converting enzyme 2 decreases expression EXP Imipramine results in decreased expression of ACE2 mRNA CTD PMID:32808185 NCBI chr  X:15,518,197...15,607,211
Ensembl chr  X:15,494,566...15,607,236
JBrowse link
G ACHE acetylcholinesterase (Yt blood group) multiple interactions
increases activity
decreases activity
EXP
ISO
Imipramine inhibits the reaction [asoxime chloride inhibits the reaction [cyclohexyl methylphosphonofluoridate results in decreased activity of ACHE protein]]; Imipramine inhibits the reaction [asoxime chloride inhibits the reaction [Sarin results in decreased activity of ACHE protein]]; Imipramine inhibits the reaction [Obidoxime Chloride metabolite results in decreased activity of ACHE protein]; Imipramine promotes the reaction [Obidoxime Chloride inhibits the reaction [Sarin results in decreased activity of ACHE protein]]
Imipramine results in increased activity of ACHE protein
Imipramine results in decreased activity of ACHE protein
CTD PMID:25522658 PMID:29614332 NCBI chr 7:100,889,994...100,896,994
Ensembl chr 7:100,889,994...100,896,974
JBrowse link
G ADRB1 adrenoceptor beta 1 multiple interactions
decreases activity
ISO [Imipramine co-treated with Idazoxan] results in decreased activity of ADRB1 protein; [Imipramine co-treated with Yohimbine] results in decreased activity of ADRB1 protein
Imipramine results in decreased activity of ADRB1 protein
CTD PMID:2868116 NCBI chr10:114,043,866...114,046,904
Ensembl chr10:114,043,866...114,046,904
JBrowse link
G ADRB2 adrenoceptor beta 2 decreases expression EXP Imipramine results in decreased expression of ADRB2 protein CTD PMID:10618463 NCBI chr 5:148,826,611...148,828,623
Ensembl chr 5:148,826,611...148,828,623
JBrowse link
G ALB albumin affects binding EXP Imipramine binds to ALB protein CTD PMID:20956006 NCBI chr 4:73,404,287...73,421,482
Ensembl chr 4:73,397,114...73,421,482
JBrowse link
G ALDH1A1 aldehyde dehydrogenase 1 family member A1 affects expression ISO Imipramine affects the expression of ALDH1A1 mRNA CTD PMID:18355885 NCBI chr 9:72,900,671...72,953,053
Ensembl chr 9:72,900,671...73,080,442
JBrowse link
G AP2M1 adaptor related protein complex 2 subunit mu 1 multiple interactions ISO Imipramine inhibits the reaction [NTRK2 protein binds to AP2M1 protein] CTD PMID:31631060 NCBI chr 3:184,174,855...184,184,091
Ensembl chr 3:184,174,689...184,184,214
JBrowse link
G APOA4 apolipoprotein A4 affects expression ISO Imipramine affects the expression of APOA4 mRNA CTD PMID:18355885 NCBI chr11:116,820,700...116,823,304
Ensembl chr11:116,820,700...116,823,304
JBrowse link
G ARG1 arginase 1 multiple interactions ISO Imipramine affects the reaction [caryophyllene inhibits the reaction [lipopolysaccharide, E coli O55-B5 results in decreased expression of ARG1 protein]] CTD PMID:30620895 NCBI chr 6:131,573,226...131,584,329
Ensembl chr 6:131,470,832...131,584,332
JBrowse link
G ASAH1 N-acylsphingosine amidohydrolase 1 increases expression EXP Imipramine results in increased expression of ASAH1 mRNA CTD PMID:15342952 PMID:17567588 NCBI chr 8:18,055,992...18,084,961
Ensembl chr 8:18,055,992...18,084,998
JBrowse link
G ASNS asparagine synthetase (glutamine-hydrolyzing) increases expression EXP Imipramine results in increased expression of ASNS mRNA CTD PMID:15342952 PMID:17567588 NCBI chr 7:97,851,677...97,928,441
Ensembl chr 7:97,851,677...97,872,542
JBrowse link
G BDNF brain derived neurotrophic factor increases expression
multiple interactions
affects expression
ISO Imipramine results in increased expression of BDNF mRNA
Rolipram promotes the reaction [Imipramine results in increased expression of BDNF mRNA]
Imipramine affects the expression of BDNF protein
CTD PMID:8601816 PMID:15157811 PMID:17617388 PMID:17950272 NCBI chr11:27,654,893...27,722,030
Ensembl chr11:27,654,893...27,722,058
JBrowse link
G BHMT betaine--homocysteine S-methyltransferase affects expression ISO Imipramine affects the expression of BHMT mRNA CTD PMID:18355885 NCBI chr 5:79,111,809...79,132,288
Ensembl chr 5:79,111,809...79,132,288
JBrowse link
G CASP3 caspase 3 multiple interactions
increases activity
EXP Imipramine results in increased cleavage of and results in increased activity of CASP3 protein; Palmitic Acid promotes the reaction [Imipramine results in increased activity of CASP3 protein] CTD PMID:10487422 PMID:22700542 NCBI chr 4:184,627,696...184,649,447
Ensembl chr 4:184,627,696...184,650,062
JBrowse link
G CASP7 caspase 7 increases activity
multiple interactions
EXP Imipramine results in increased activity of CASP7 protein
Palmitic Acid promotes the reaction [Imipramine results in increased activity of CASP7 protein]
CTD PMID:22700542 NCBI chr10:113,679,194...113,730,909
Ensembl chr10:113,679,162...113,730,907
JBrowse link
G CASP8 caspase 8 multiple interactions ISO Imipramine inhibits the reaction [lead acetate results in increased activity of CASP8 protein] CTD PMID:22033380 NCBI chr 2:201,233,463...201,287,711
Ensembl chr 2:201,233,443...201,361,836
JBrowse link
G CAT catalase affects activity
multiple interactions
ISO Imipramine affects the activity of CAT protein
Imipramine inhibits the reaction [Streptozocin results in increased activity of CAT protein]
CTD PMID:19798453 PMID:34352274 NCBI chr11:34,438,934...34,472,060
Ensembl chr11:34,438,934...34,472,060
JBrowse link
G CDKN2C cyclin dependent kinase inhibitor 2C affects expression ISO Imipramine affects the expression of CDKN2C mRNA CTD PMID:18355885 NCBI chr 1:50,968,706...50,974,634
Ensembl chr 1:50,960,745...50,974,634
JBrowse link
G CES2 carboxylesterase 2 affects expression ISO Imipramine affects the expression of CES2 mRNA CTD PMID:18355885 NCBI chr16:66,934,471...66,945,096
Ensembl chr16:66,934,444...66,945,096
JBrowse link
G CMTM6 CKLF like MARVEL transmembrane domain containing 6 affects expression ISO Imipramine affects the expression of CMTM6 mRNA CTD PMID:18355885 NCBI chr 3:32,481,312...32,502,852
Ensembl chr 3:32,481,312...32,502,852
JBrowse link
G CNR1 cannabinoid receptor 1 decreases expression ISO Imipramine results in decreased expression of CNR1 protein CTD PMID:28866072 NCBI chr 6:88,139,864...88,167,349
Ensembl chr 6:88,139,864...88,166,347
JBrowse link
G CNR2 cannabinoid receptor 2 increases expression ISO Imipramine results in increased expression of CNR2 protein CTD PMID:28866072 NCBI chr 1:23,870,515...23,913,362
Ensembl chr 1:23,870,515...23,913,362
JBrowse link
G CPPED1 calcineurin like phosphoesterase domain containing 1 affects expression ISO Imipramine affects the expression of CPPED1 mRNA CTD PMID:18355885 NCBI chr16:12,659,799...12,803,887
Ensembl chr16:12,659,799...12,803,887
JBrowse link
G CREB1 cAMP responsive element binding protein 1 increases expression
increases phosphorylation
multiple interactions
ISO Imipramine results in increased expression of CREB1 mRNA
Imipramine results in increased phosphorylation of CREB1 protein
Rolipram promotes the reaction [Imipramine results in increased expression of CREB1 mRNA]
CTD PMID:8601816 PMID:22396798 NCBI chr 2:207,529,962...207,605,988
Ensembl chr 2:207,529,737...207,605,988
JBrowse link
G CREM cAMP responsive element modulator affects expression ISO Imipramine affects the expression of CREM mRNA CTD PMID:18355885 NCBI chr10:35,126,846...35,212,958
Ensembl chr10:35,126,791...35,212,958
JBrowse link
G CRH corticotropin releasing hormone affects activity ISO Imipramine affects the activity of CRH protein CTD PMID:2553044 NCBI chr 8:66,176,376...66,178,464
Ensembl chr 8:66,176,376...66,178,464
JBrowse link
G CYP1A2 cytochrome P450 family 1 subfamily A member 2 affects metabolic processing
increases metabolic processing
multiple interactions
EXP CYP1A2 protein affects the metabolism of Imipramine
CYP1A2 protein results in increased metabolism of Imipramine
CYP1A2 protein results in decreased methylation of and results in increased activity of Imipramine; Imipramine inhibits the reaction [resveratrol results in decreased activity of CYP1A2 protein]; Organophosphorus Compounds inhibits the reaction [CYP1A2 protein results in decreased methylation of and results in increased activity of Imipramine]
CTD PMID:11714871 PMID:15286053 PMID:15922009 NCBI chr15:74,748,845...74,756,607
Ensembl chr15:74,748,845...74,756,607
JBrowse link
G CYP2A13 cytochrome P450 family 2 subfamily A member 13 affects expression ISO Imipramine affects the expression of CYP2A1 mRNA CTD PMID:18355885 NCBI chr19:41,088,451...41,096,195
Ensembl chr19:41,088,451...41,096,195
JBrowse link
G CYP2C19 cytochrome P450 family 2 subfamily C member 19 affects metabolic processing
multiple interactions
EXP CYP2C19 protein affects the metabolism of Imipramine
CYP2C19 protein results in decreased methylation of and results in increased activity of Imipramine; Organophosphorus Compounds inhibits the reaction [CYP2C19 protein results in decreased methylation of and results in increased activity of Imipramine]
CTD PMID:15286053 PMID:15922009 NCBI chr10:94,762,681...94,855,547
Ensembl chr10:94,762,681...94,855,547
JBrowse link
G CYP2D6 cytochrome P450 family 2 subfamily D member 6 affects metabolic processing EXP CYP2D6 protein affects the metabolism of Imipramine CTD PMID:15286053 NCBI chr22:42,126,499...42,130,810
Ensembl chr22:42,126,499...42,130,865
JBrowse link
G CYP3A4 cytochrome P450 family 3 subfamily A member 4 multiple interactions EXP CYP3A4 protein results in decreased methylation of and results in increased activity of Imipramine; Organophosphorus Compounds inhibits the reaction [CYP3A4 protein results in decreased methylation of and results in increased activity of Imipramine] CTD PMID:15922009 NCBI chr 7:99,756,967...99,784,184
Ensembl chr 7:99,756,960...99,784,248
JBrowse link
G CYP4F12 cytochrome P450 family 4 subfamily F member 12 affects expression ISO Imipramine affects the expression of CYP4F2 mRNA CTD PMID:18355885 NCBI chr19:15,673,087...15,697,174
Ensembl chr19:15,673,018...15,697,174
JBrowse link
G DCAF8 DDB1 and CUL4 associated factor 8 affects expression ISO Imipramine affects the expression of DCAF8 mRNA CTD PMID:18355885 NCBI chr 1:160,215,720...160,262,549
Ensembl chr 1:160,215,715...160,262,549
JBrowse link
G DEPP1 DEPP autophagy regulator 1 increases expression EXP Imipramine results in increased expression of DEPP1 mRNA CTD PMID:15342952 PMID:17567588 NCBI chr10:44,976,128...44,978,809
Ensembl chr10:44,970,981...44,978,809
JBrowse link
G DNAJC5 DnaJ heat shock protein family (Hsp40) member C5 increases expression EXP Imipramine results in increased expression of DNAJC5 mRNA; Imipramine results in increased expression of DNAJC5 protein CTD PMID:11257428 NCBI chr20:63,895,126...63,936,011
Ensembl chr20:63,895,126...63,936,031
JBrowse link
G EIF4B eukaryotic translation initiation factor 4B affects expression ISO Imipramine affects the expression of EIF4B mRNA CTD PMID:18355885 NCBI chr12:53,006,456...53,042,215
Ensembl chr12:53,006,282...53,042,215
JBrowse link
G EPHX1 epoxide hydrolase 1 affects expression ISO Imipramine affects the expression of EPHX1 mRNA CTD PMID:18355885 NCBI chr 1:225,810,124...225,845,563
Ensembl chr 1:225,810,124...225,845,563
JBrowse link
G ERP29 endoplasmic reticulum protein 29 affects expression ISO Imipramine affects the expression of ERP29 mRNA CTD PMID:18355885 NCBI chr12:112,013,426...112,023,449
Ensembl chr12:112,013,348...112,023,449
JBrowse link
G FABP1 fatty acid binding protein 1 increases expression EXP Imipramine results in increased expression of FABP1 mRNA CTD PMID:15342952 PMID:17567588 NCBI chr 2:88,122,982...88,128,062
Ensembl chr 2:88,122,982...88,128,062
JBrowse link
G FNDC4 fibronectin type III domain containing 4 increases expression EXP Imipramine results in increased expression of FNDC4 mRNA CTD PMID:15342952 PMID:17567588 NCBI chr 2:27,491,883...27,495,200
Ensembl chr 2:27,491,883...27,495,200
JBrowse link
G FOS Fos proto-oncogene, AP-1 transcription factor subunit decreases expression ISO Imipramine results in decreased expression of FOS mRNA CTD PMID:7612155 NCBI chr14:75,278,828...75,282,230
Ensembl chr14:75,278,826...75,282,230
JBrowse link
G GAP43 growth associated protein 43 decreases expression ISO Imipramine results in decreased expression of GAP43 mRNA CTD PMID:17950272 NCBI chr 3:115,623,510...115,721,483
Ensembl chr 3:115,623,510...115,721,490
JBrowse link
G GCKR glucokinase regulator affects expression ISO Imipramine affects the expression of GCKR mRNA CTD PMID:18355885 NCBI chr 2:27,496,839...27,523,684
Ensembl chr 2:27,496,839...27,523,684
JBrowse link
G GDPD3 glycerophosphodiester phosphodiesterase domain containing 3 increases expression EXP Imipramine results in increased expression of GDPD3 mRNA CTD PMID:15342952 PMID:17567588 NCBI chr16:30,104,810...30,113,537
Ensembl chr16:30,104,810...30,113,537
JBrowse link
G GLS2 glutaminase 2 affects expression ISO Imipramine affects the expression of GLS2 mRNA CTD PMID:18355885 NCBI chr12:56,470,952...56,488,161
Ensembl chr12:56,470,944...56,488,414
JBrowse link
G GOT2 glutamic-oxaloacetic transaminase 2 affects expression ISO Imipramine affects the expression of GOT2 mRNA CTD PMID:18355885 NCBI chr16:58,707,131...58,734,316
Ensembl chr16:58,707,131...58,734,342
JBrowse link
G GRB14 growth factor receptor bound protein 14 affects expression ISO Imipramine affects the expression of GRB14 mRNA CTD PMID:18355885 NCBI chr 2:164,492,417...164,621,482
Ensembl chr 2:164,492,417...164,621,482
JBrowse link
G GRIN1 glutamate ionotropic receptor NMDA type subunit 1 decreases expression EXP Imipramine results in decreased expression of GRIN1 mRNA CTD PMID:34748853 NCBI chr 9:137,139,154...137,168,756
Ensembl chr 9:137,138,346...137,168,756
JBrowse link
G GSTP1 glutathione S-transferase pi 1 decreases activity EXP Imipramine results in decreased activity of GSTP1 protein CTD PMID:15094841 NCBI chr11:67,583,812...67,586,653
Ensembl chr11:67,583,742...67,586,656
JBrowse link
G HAL histidine ammonia-lyase affects expression ISO Imipramine affects the expression of HAL mRNA CTD PMID:18355885 NCBI chr12:95,972,662...95,996,344
Ensembl chr12:95,972,662...95,996,365
JBrowse link
G HDAC5 histone deacetylase 5 increases expression ISO Imipramine results in increased expression of HDAC5 mRNA CTD PMID:17988634 NCBI chr17:44,076,753...44,123,641
Ensembl chr17:44,076,746...44,123,702
JBrowse link
G HMBS hydroxymethylbilane synthase decreases activity ISO Imipramine results in decreased activity of HMBS protein CTD PMID:10416826 NCBI chr11:119,084,881...119,093,549
Ensembl chr11:119,084,866...119,093,834
JBrowse link
G HMGB2 high mobility group box 2 affects expression ISO Imipramine affects the expression of HMGB2 mRNA CTD PMID:18355885 NCBI chr 4:173,331,376...173,334,358
Ensembl chr 4:173,331,376...173,334,432
JBrowse link
G HMGCS1 3-hydroxy-3-methylglutaryl-CoA synthase 1 increases expression EXP Imipramine results in increased expression of HMGCS1 mRNA CTD PMID:16324787 NCBI chr 5:43,287,470...43,313,412
Ensembl chr 5:43,287,470...43,313,512
JBrowse link
G HPN hepsin increases expression EXP Imipramine results in increased expression of HPN mRNA CTD PMID:15342952 PMID:17567588 NCBI chr19:35,040,506...35,066,573
Ensembl chr19:35,040,506...35,066,573
JBrowse link
G HSF1 heat shock transcription factor 1 decreases activity EXP Imipramine results in decreased activity of HSF1 protein CTD PMID:34170685 NCBI chr 8:144,291,604...144,314,720
Ensembl chr 8:144,291,591...144,314,720
JBrowse link
G HSPA8 heat shock protein family A (Hsp70) member 8 increases expression ISO Imipramine results in increased expression of HSPA8 mRNA alternative form; Imipramine results in increased expression of HSPA8 protein alternative form CTD PMID:10425221 NCBI chr11:123,057,489...123,062,462
Ensembl chr11:123,057,489...123,063,230
JBrowse link
G HTR1A 5-hydroxytryptamine receptor 1A affects expression ISO Imipramine affects the expression of HTR1A mRNA CTD PMID:17617388 NCBI chr 5:63,957,874...63,962,445
Ensembl chr 5:63,957,874...63,962,507
JBrowse link
G HTR2A 5-hydroxytryptamine receptor 2A decreases expression ISO Imipramine results in decreased expression of HTR2A CTD PMID:2553044 NCBI chr13:46,831,546...46,898,082
Ensembl chr13:46,831,546...46,897,076
JBrowse link
G IL10 interleukin 10 multiple interactions ISO Imipramine affects the reaction [caryophyllene promotes the reaction [lipopolysaccharide, E coli O55-B5 results in increased secretion of IL10 protein]] CTD PMID:30620895 NCBI chr 1:206,767,602...206,772,494
Ensembl chr 1:206,767,602...206,774,541
JBrowse link
G IL1B interleukin 1 beta multiple interactions ISO Imipramine affects the reaction [caryophyllene inhibits the reaction [lipopolysaccharide, E coli O55-B5 results in increased secretion of IL1B protein]]; Imipramine inhibits the reaction [lipopolysaccharide, E coli O55-B5 results in increased secretion of IL1B protein] CTD PMID:30620895 NCBI chr 2:112,829,751...112,836,779
Ensembl chr 2:112,829,751...112,836,816
JBrowse link
G IL33 interleukin 33 affects expression ISO Imipramine affects the expression of IL33 mRNA CTD PMID:18355885 NCBI chr 9:6,215,149...6,257,983
Ensembl chr 9:6,215,786...6,257,983
JBrowse link
G INHBE inhibin subunit beta E increases expression EXP Imipramine results in increased expression of INHBE mRNA CTD PMID:15342952 PMID:17567588 NCBI chr12:57,455,307...57,458,025
Ensembl chr12:57,452,323...57,459,280
JBrowse link
G KCNH1 potassium voltage-gated channel subfamily H member 1 multiple interactions EXP Imipramine binds to and results in decreased activity of KCNH1 protein CTD PMID:18497958 NCBI chr 1:210,678,314...211,134,148
Ensembl chr 1:210,676,823...211,134,165
JBrowse link
G KCNH2 potassium voltage-gated channel subfamily H member 2 multiple interactions
decreases activity
decreases localization
EXP
ISO
Imipramine binds to and results in decreased activity of KCNH2 protein; Imipramine inhibits the reaction [KCNH2 protein results in increased transport of Thallium]
Imipramine results in decreased activity of KCNH2 protein
Imipramine results in decreased localization of KCNH2 protein
CTD PMID:15272206 PMID:19583963 PMID:21158687 PMID:21525004 PMID:24052561 NCBI chr 7:150,944,961...150,978,321
Ensembl chr 7:150,944,961...150,978,321
JBrowse link
G KCNN2 potassium calcium-activated channel subfamily N member 2 decreases activity ISO Imipramine results in decreased activity of KCNN2 protein CTD PMID:10915830 NCBI chr 5:114,055,978...114,496,496
Ensembl chr 5:114,055,926...114,496,500
JBrowse link
G LOX lysyl oxidase affects expression ISO Imipramine affects the expression of LOX mRNA CTD PMID:18355885 NCBI chr 5:122,063,195...122,078,259
Ensembl chr 5:122,063,195...122,078,413
JBrowse link
G LSS lanosterol synthase increases expression EXP Imipramine results in increased expression of LSS mRNA CTD PMID:15342952 PMID:17567588 NCBI chr21:46,188,446...46,228,774
Ensembl chr21:46,188,141...46,228,824
JBrowse link
G MACROH2A1 macroH2A.1 histone affects expression ISO Imipramine affects the expression of MACROH2A1 mRNA CTD PMID:18355885 NCBI chr 5:135,334,381...135,399,887
Ensembl chr 5:135,334,381...135,399,914
JBrowse link
G MANBA mannosidase beta affects expression ISO Imipramine affects the expression of MANBA mRNA CTD PMID:18355885 NCBI chr 4:102,630,770...102,760,968
Ensembl chr 4:102,630,770...102,760,994
JBrowse link
G MAPK1 mitogen-activated protein kinase 1 multiple interactions ISO 2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [Imipramine binds to and results in increased activity of MAPK1 protein]; Imipramine binds to and results in increased activity of MAPK1 protein CTD PMID:20484120 NCBI chr22:21,759,657...21,867,680
Ensembl chr22:21,759,657...21,867,680
JBrowse link
G MAPK3 mitogen-activated protein kinase 3 multiple interactions ISO 2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [Imipramine binds to and results in increased activity of MAPK3 protein]; Imipramine binds to and results in increased activity of MAPK3 protein CTD PMID:20484120 NCBI chr16:30,114,105...30,123,220
Ensembl chr16:30,114,105...30,123,506
JBrowse link
G MLX MAX dimerization protein MLX affects expression ISO Imipramine affects the expression of MLX mRNA CTD PMID:18355885 NCBI chr17:42,567,100...42,573,203
Ensembl chr17:42,567,072...42,573,239
JBrowse link
G MRPS18B mitochondrial ribosomal protein S18B affects expression ISO Imipramine affects the expression of MRPS18B mRNA CTD PMID:18355885 NCBI chr 6:30,617,840...30,626,392
Ensembl chr 6:30,617,840...30,626,395
JBrowse link
G MSMO1 methylsterol monooxygenase 1 affects expression ISO Imipramine affects the expression of MSMO1 mRNA CTD PMID:18355885 NCBI chr 4:165,327,669...165,343,164
Ensembl chr 4:165,327,667...165,343,164
JBrowse link
G NR0B2 nuclear receptor subfamily 0 group B member 2 increases expression EXP Imipramine results in increased expression of NR0B2 mRNA CTD PMID:15342952 NCBI chr 1:26,911,489...26,913,975
Ensembl chr 1:26,911,489...26,913,975
JBrowse link
G NREP neuronal regeneration related protein affects expression ISO Imipramine affects the expression of NREP mRNA CTD PMID:18355885 NCBI chr 5:111,728,802...111,976,932
Ensembl chr 5:111,662,621...111,997,464
JBrowse link
G NTRK2 neurotrophic receptor tyrosine kinase 2 multiple interactions
increases phosphorylation
ISO Imipramine inhibits the reaction [NTRK2 protein binds to AP2M1 protein]; Imipramine promotes the reaction [NTRK2 protein binds to PLCG1 protein modified form]; Imipramine results in increased phosphorylation of and results in increased activity of NTRK2 protein
Imipramine results in increased phosphorylation of NTRK2 protein
CTD PMID:21666748 PMID:22396798 PMID:31631060 NCBI chr 9:84,668,522...85,027,054
Ensembl chr 9:84,668,375...85,095,751
JBrowse link
G NUPR1 nuclear protein 1, transcriptional regulator increases expression EXP Imipramine results in increased expression of NUPR1 mRNA CTD PMID:15342952 PMID:17567588 NCBI chr16:28,532,708...28,538,974
Ensembl chr16:28,532,708...28,539,008
JBrowse link
G OAF out at first homolog affects expression ISO Imipramine affects the expression of OAF mRNA CTD PMID:18355885 NCBI chr11:120,211,032...120,230,334
Ensembl chr11:120,211,032...120,230,334
JBrowse link
G ORM2 orosomucoid 2 multiple interactions
affects binding
EXP Chlorpromazine inhibits the reaction [Imipramine binds to ORM2 protein alternative form]; Dipyridamole inhibits the reaction [Imipramine binds to ORM2 protein alternative form]; Disopyramide inhibits the reaction [Imipramine binds to ORM2 protein alternative form]; Lidocaine inhibits the reaction [Imipramine binds to ORM2 protein alternative form]; Methadone inhibits the reaction [Imipramine binds to ORM2 protein alternative form]; Progesterone inhibits the reaction [Imipramine binds to ORM2 protein alternative form] CTD PMID:8946472 NCBI chr 9:114,329,869...114,333,251
Ensembl chr 9:114,329,869...114,333,251
JBrowse link
G PARP1 poly(ADP-ribose) polymerase 1 increases cleavage EXP Imipramine results in increased cleavage of PARP1 protein CTD PMID:10487422 NCBI chr 1:226,360,691...226,408,093
Ensembl chr 1:226,360,210...226,408,154
JBrowse link
G PC pyruvate carboxylase affects expression ISO Imipramine affects the expression of PC mRNA CTD PMID:18355885 NCBI chr11:66,848,420...66,958,383
Ensembl chr11:66,848,417...66,958,386
JBrowse link
G PECR peroxisomal trans-2-enoyl-CoA reductase affects expression ISO Imipramine affects the expression of PECR mRNA CTD PMID:18355885 NCBI chr 2:216,029,088...216,081,809
Ensembl chr 2:215,996,329...216,082,955
JBrowse link
G PLCG1 phospholipase C gamma 1 multiple interactions ISO Imipramine promotes the reaction [NTRK2 protein binds to PLCG1 protein modified form] CTD PMID:22396798 NCBI chr20:41,137,543...41,177,626
Ensembl chr20:41,136,960...41,196,801
JBrowse link
G POMC proopiomelanocortin multiple interactions EXP Imipramine inhibits the reaction [Buspirone results in increased expression of POMC protein] CTD PMID:19762159 NCBI chr 2:25,160,860...25,168,580
Ensembl chr 2:25,160,853...25,168,903
JBrowse link
G POR cytochrome p450 oxidoreductase affects expression ISO Imipramine affects the expression of POR mRNA CTD PMID:18355885 NCBI chr 7:75,915,155...75,986,855
Ensembl chr 7:75,899,200...75,986,855
JBrowse link
G PPP2CA protein phosphatase 2 catalytic subunit alpha multiple interactions ISO Imipramine inhibits the reaction [Ethanol results in increased activity of PPP2CA protein] CTD PMID:20224005 NCBI chr 5:134,194,332...134,226,073
Ensembl chr 5:134,194,035...134,226,073
JBrowse link
G RBL2 RB transcriptional corepressor like 2 affects expression ISO Imipramine affects the expression of RBL2 mRNA CTD PMID:18355885 NCBI chr16:53,434,471...53,491,648
Ensembl chr16:53,433,977...53,491,648
JBrowse link
G SCD stearoyl-CoA desaturase increases expression EXP Imipramine results in increased expression of SCD mRNA CTD PMID:16324787 NCBI chr10:100,347,233...100,364,826
Ensembl chr10:100,347,233...100,364,826
JBrowse link
G SERPINA3 serpin family A member 3 increases expression EXP Imipramine results in increased expression of SERPINA3 mRNA CTD PMID:15342952 PMID:17567588 NCBI chr14:94,612,391...94,624,053
Ensembl chr14:94,612,384...94,624,055
JBrowse link
G SERPINI1 serpin family I member 1 increases expression ISO Imipramine results in increased expression of SERPINI1 mRNA CTD PMID:16637596 NCBI chr 3:167,735,721...167,825,569
Ensembl chr 3:167,735,243...167,825,569
JBrowse link
G SH3GL3 SH3 domain containing GRB2 like 3, endophilin A3 affects expression ISO Imipramine affects the expression of SH3GL3 mRNA CTD PMID:18355885 NCBI chr15:83,447,341...83,633,820
Ensembl chr15:83,447,228...83,618,743
JBrowse link
G SHANK2 SH3 and multiple ankyrin repeat domains 2 decreases expression EXP Imipramine results in decreased expression of SHANK2 mRNA CTD PMID:34748853 NCBI chr11:70,467,854...71,253,228
Ensembl chr11:70,467,854...71,252,577
JBrowse link
G SLC22A1 solute carrier family 22 member 1 multiple interactions EXP Imipramine inhibits the reaction [SLC22A1 protein results in increased uptake of Metformin]; Imipramine inhibits the reaction [SLC22A1 protein results in increased uptake of Quercetin]; Imipramine inhibits the reaction [SLC22A1 protein results in increased uptake of Tetraethylammonium] CTD PMID:24947867 PMID:25106415 NCBI chr 6:160,121,815...160,158,718
Ensembl chr 6:160,121,815...160,158,718
JBrowse link
G SLC22A2 solute carrier family 22 member 2 multiple interactions EXP Imipramine inhibits the reaction [SLC22A2 protein polymorphism results in increased uptake of 4-(4-dimethylaminostyryl)-1-methylpyridinium]; Imipramine inhibits the reaction [SLC22A2 protein results in increased uptake of 4-(4-dimethylaminostyryl)-1-methylpyridinium] CTD PMID:21599003 NCBI chr 6:160,216,755...160,258,821
Ensembl chr 6:160,171,061...160,277,638
JBrowse link
G SLC22A3 solute carrier family 22 member 3 multiple interactions EXP Imipramine inhibits the reaction [SLC22A3 protein results in increased uptake of 1-Methyl-4-phenylpyridinium analog]; Imipramine inhibits the reaction [SLC22A3 protein results in increased uptake of 1-Methyl-4-phenylpyridinium]; Imipramine inhibits the reaction [SLC22A3 protein results in increased uptake of Metformin] CTD PMID:10966924 PMID:21697722 NCBI chr 6:160,348,378...160,452,577
Ensembl chr 6:160,348,378...160,452,577
JBrowse link
G SLC2A3 solute carrier family 2 member 3 decreases expression EXP Imipramine results in decreased expression of SLC2A3 mRNA CTD PMID:15342952 PMID:17567588 NCBI chr12:7,919,230...7,936,187
Ensembl chr12:7,919,230...8,019,007
JBrowse link
G SLC47A1 solute carrier family 47 member 1 decreases activity
multiple interactions
EXP Imipramine results in decreased activity of SLC47A1 protein
Imipramine inhibits the reaction [SLC47A1 protein results in increased uptake of 4-(4-dimethylaminostyryl)-1-methylpyridinium]
CTD PMID:16928787 PMID:21599003 NCBI chr17:19,533,854...19,579,034
Ensembl chr17:19,495,385...19,579,034
JBrowse link
G SLC6A4 solute carrier family 6 member 4 decreases activity ISO Imipramine results in decreased activity of SLC6A4 protein CTD PMID:18561912 NCBI chr17:30,194,319...30,235,697
Ensembl chr17:30,194,319...30,236,002
JBrowse link
G SLC6A6 solute carrier family 6 member 6 affects expression ISO Imipramine affects the expression of SLC6A6 mRNA CTD PMID:18355885 NCBI chr 3:14,402,576...14,489,349
Ensembl chr 3:14,402,576...14,489,349
JBrowse link
G SLCO1A2 solute carrier organic anion transporter family member 1A2 affects expression ISO Imipramine affects the expression of SLCO1A4 mRNA CTD PMID:18355885 NCBI chr12:21,264,600...21,419,634
Ensembl chr12:21,264,600...21,419,594
JBrowse link
G SREBF1 sterol regulatory element binding transcription factor 1 multiple interactions EXP Imipramine results in increased cleavage of and results in increased activity of SREBF1 protein CTD PMID:16324787 NCBI chr17:17,811,334...17,836,986
Ensembl chr17:17,810,399...17,837,002
JBrowse link
G SREBF2 sterol regulatory element binding transcription factor 2 multiple interactions EXP Imipramine results in increased cleavage of and results in increased activity of SREBF2 protein CTD PMID:16324787 NCBI chr22:41,833,105...41,907,305
Ensembl chr22:41,833,105...41,907,306
JBrowse link
G ST13 ST13 Hsp70 interacting protein affects expression ISO Imipramine affects the expression of ST13 mRNA CTD PMID:18355885 NCBI chr22:40,824,535...40,856,639
Ensembl chr22:40,824,535...40,856,639
JBrowse link
G STBD1 starch binding domain 1 affects expression ISO Imipramine affects the expression of STBD1 mRNA CTD PMID:18355885 NCBI chr 4:76,306,733...76,311,130
Ensembl chr 4:76,306,733...76,311,130
JBrowse link
G STMN1 stathmin 1 affects expression ISO Imipramine affects the expression of STMN1 mRNA CTD PMID:18355885 NCBI chr 1:25,884,179...25,906,880
Ensembl chr 1:25,884,181...25,906,991
JBrowse link
G TAC1 tachykinin precursor 1 decreases expression ISO Imipramine results in decreased expression of TAC1 protein CTD PMID:8955926 NCBI chr 7:97,732,086...97,740,472
Ensembl chr 7:97,732,084...97,740,472
JBrowse link
G TAGLN transgelin decreases expression EXP Imipramine results in decreased expression of TAGLN mRNA CTD PMID:15342952 PMID:17567588 NCBI chr11:117,199,294...117,207,465
Ensembl chr11:117,199,370...117,207,464
JBrowse link
G TEX261 testis expressed 261 affects expression ISO Imipramine affects the expression of TEX261 mRNA CTD PMID:18355885 NCBI chr 2:70,985,942...70,994,873
Ensembl chr 2:70,968,325...70,994,873
JBrowse link
G TIMM10B translocase of inner mitochondrial membrane 10B affects expression ISO Imipramine affects the expression of TIMM10B mRNA CTD PMID:18355885 NCBI chr11:6,481,501...6,484,681
Ensembl chr11:6,481,501...6,484,681
JBrowse link
G TMPRSS2 transmembrane serine protease 2 increases expression EXP Imipramine results in increased expression of TMPRSS2 mRNA CTD PMID:32808185 NCBI chr21:41,464,305...41,508,158
Ensembl chr21:41,464,300...41,531,116
JBrowse link
G TNF tumor necrosis factor multiple interactions ISO Imipramine affects the reaction [caryophyllene inhibits the reaction [lipopolysaccharide, E coli O55-B5 results in increased secretion of TNF protein]]; Imipramine inhibits the reaction [lipopolysaccharide, E coli O55-B5 results in increased secretion of TNF protein]; Imipramine inhibits the reaction [TNF protein results in increased abundance of N-palmitoylsphingosine]
Imipramine inhibits the reaction [lipopolysaccharide, E coli O55-B5 results in increased expression of TNF protein]; Imipramine promotes the reaction [caryophyllene inhibits the reaction [lipopolysaccharide, E coli O55-B5 results in increased expression of TNF protein]]
CTD PMID:15946935 PMID:30529211 PMID:30620895 NCBI chr 6:31,575,565...31,578,336
Ensembl chr 6:31,575,565...31,578,336
JBrowse link
G UBA52 ubiquitin A-52 residue ribosomal protein fusion product 1 affects expression ISO Imipramine affects the expression of UBA52 mRNA CTD PMID:18355885 NCBI chr19:18,563,766...18,577,550
Ensembl chr19:18,571,730...18,577,550
JBrowse link
G UGT1A1 UDP glucuronosyltransferase family 1 member A1 affects expression ISO Imipramine affects the expression of UGT1A1 mRNA CTD PMID:18355885 NCBI chr 2:233,760,270...233,773,300
Ensembl chr 2:233,760,270...233,773,300
JBrowse link
G UGT1A4 UDP glucuronosyltransferase family 1 member A4 affects metabolic processing
multiple interactions
increases glucuronidation
EXP UGT1A4 protein affects the metabolism of Imipramine
Finasteride inhibits the reaction [UGT1A4 protein results in increased glucuronidation of Imipramine]
UGT1A4 protein results in increased glucuronidation of Imipramine; UGT1A4 protein SNP results in increased glucuronidation of Imipramine
CTD PMID:9264550 PMID:14570768 PMID:15286053 PMID:15708967 PMID:25448279 NCBI chr 2:233,718,736...233,773,300
Ensembl chr 2:233,718,736...233,773,300
JBrowse link
G UGT2A1 UDP glucuronosyltransferase family 2 member A1 complex locus affects expression ISO Imipramine affects the expression of UGT2A1 mRNA CTD PMID:18355885 NCBI chr 4:69,588,417...69,653,247
Ensembl chr 4:69,588,417...69,653,249
JBrowse link
G UGT2B17 UDP glucuronosyltransferase family 2 member B17 affects expression ISO Imipramine affects the expression of UGT2B1 mRNA CTD PMID:18355885 NCBI chr 4:68,537,173...68,576,322
Ensembl chr 4:68,537,173...68,576,413
JBrowse link
G WIPI1 WD repeat domain, phosphoinositide interacting 1 increases expression EXP Imipramine results in increased expression of WIPI1 mRNA CTD PMID:15342952 PMID:17567588 NCBI chr17:68,421,281...68,457,496
Ensembl chr17:68,420,948...68,457,513
JBrowse link
oxanthrene term browser
Symbol Object Name Qualifiers Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
G CYP1A1 cytochrome P450 family 1 subfamily A member 1 affects abundance EXP CYP1A1 gene polymorphism affects the abundance of dibenzo(1,4)dioxin CTD PMID:23528250 NCBI chr15:74,719,542...74,725,528
Ensembl chr15:74,719,542...74,725,536
JBrowse link
perazine term browser
Symbol Object Name Qualifiers Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
G CYP2C9 cytochrome P450 family 2 subfamily C member 9 affects metabolic processing
decreases methylation
EXP CYP2C9 gene polymorphism affects the metabolism of Perazine
CYP2C9 protein results in decreased methylation of Perazine
CTD PMID:11026737 NCBI chr10:94,938,658...94,990,091
Ensembl chr10:94,938,658...94,990,091
JBrowse link
G CYP3A4 cytochrome P450 family 3 subfamily A member 4 decreases methylation EXP CYP3A4 protein results in decreased methylation of Perazine CTD PMID:11026737 NCBI chr 7:99,756,967...99,784,184
Ensembl chr 7:99,756,960...99,784,248
JBrowse link
G FMO3 flavin containing dimethylaniline monoxygenase 3 increases oxidation EXP FMO3 protein results in increased oxidation of Perazine CTD PMID:11026737 NCBI chr 1:171,090,905...171,117,819
Ensembl chr 1:171,090,901...171,117,819
JBrowse link
periciazine term browser
Symbol Object Name Qualifiers Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
G AR androgen receptor multiple interactions EXP periciazine binds to and results in decreased activity of AR protein CTD PMID:17606915 NCBI chr  X:67,544,021...67,730,619
Ensembl chr  X:67,544,021...67,730,619
JBrowse link
G KCNH2 potassium voltage-gated channel subfamily H member 2 decreases activity EXP periciazine results in decreased activity of KCNH2 protein CTD PMID:28551711 NCBI chr 7:150,944,961...150,978,321
Ensembl chr 7:150,944,961...150,978,321
JBrowse link
perphenazine term browser
Symbol Object Name Qualifiers Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
G CES1 carboxylesterase 1 multiple interactions EXP Perphenazine inhibits the reaction [CES1 protein results in increased hydrolysis of 4-nitrophenyl acetate]; Perphenazine inhibits the reaction [CES1 protein results in increased hydrolysis of Methylphenidate] CTD PMID:20097249 NCBI chr16:55,802,851...55,833,096
Ensembl chr16:55,802,851...55,833,337
JBrowse link
G CYP1A1 cytochrome P450 family 1 subfamily A member 1 multiple interactions EXP
ISO
Perphenazine inhibits the reaction [Tetrachlorodibenzodioxin results in increased activity of CYP1A1 protein] CTD PMID:18493746 NCBI chr15:74,719,542...74,725,528
Ensembl chr15:74,719,542...74,725,536
JBrowse link
G FSHB follicle stimulating hormone subunit beta decreases expression ISO Perphenazine results in decreased expression of FSHB protein CTD PMID:6770916 NCBI chr11:30,231,014...30,235,194
Ensembl chr11:30,231,014...30,235,261
JBrowse link
G KCNH2 potassium voltage-gated channel subfamily H member 2 multiple interactions
decreases activity
EXP Perphenazine inhibits the reaction [KCNH2 protein results in increased transport of Thallium]
Perphenazine results in decreased activity of KCNH2 protein
CTD PMID:21158687 PMID:28551711 NCBI chr 7:150,944,961...150,978,321
Ensembl chr 7:150,944,961...150,978,321
JBrowse link
G LHB luteinizing hormone subunit beta decreases expression ISO Perphenazine results in decreased expression of LHB protein CTD PMID:6770916 NCBI chr19:49,015,980...49,019,498
Ensembl chr19:49,015,980...49,017,091
JBrowse link
G PRL prolactin increases expression EXP
ISO
Perphenazine results in increased expression of PRL protein CTD PMID:6770916 PMID:7262630 PMID:17335319 NCBI chr 6:22,287,246...22,302,835
Ensembl chr 6:22,287,244...22,302,826
JBrowse link
G SLC22A2 solute carrier family 22 member 2 multiple interactions EXP Perphenazine inhibits the reaction [SLC22A2 protein results in increased uptake of 4-(4-dimethylaminostyryl)-1-methylpyridinium] CTD PMID:21599003 NCBI chr 6:160,216,755...160,258,821
Ensembl chr 6:160,171,061...160,277,638
JBrowse link
G TNNI3 troponin I3, cardiac type increases expression EXP Perphenazine results in increased expression of TNNI3 protein CTD PMID:14742781 NCBI chr19:55,151,767...55,157,732
Ensembl chr19:55,151,767...55,157,773
JBrowse link
prochlorperazine term browser
Symbol Object Name Qualifiers Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
G ACHE acetylcholinesterase (Yt blood group) increases activity ISO Prochlorperazine results in increased activity of ACHE protein CTD PMID:29614332 NCBI chr 7:100,889,994...100,896,994
Ensembl chr 7:100,889,994...100,896,974
JBrowse link
G ESR1 estrogen receptor 1 multiple interactions EXP Prochlorperazine binds to and results in increased activity of ESR1 protein CTD PMID:25752796 NCBI chr 6:151,656,672...152,129,619
Ensembl chr 6:151,656,691...152,129,619
JBrowse link
G TFEB transcription factor EB affects localization EXP Prochlorperazine affects the localization of TFEB protein CTD PMID:28366621 NCBI chr 6:41,683,978...41,736,223
Ensembl chr 6:41,683,978...41,736,259
JBrowse link
quinacrine term browser
Symbol Object Name Qualifiers Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
G ABCB1 ATP binding cassette subfamily B member 1 increases transport
multiple interactions
EXP ABCB1 protein results in increased transport of Quinacrine
Elacridar inhibits the reaction [ABCB1 protein results in increased transport of Quinacrine]
CTD PMID:16581945 NCBI chr 7:87,503,017...87,713,295
Ensembl chr 7:87,503,017...87,713,323
JBrowse link
G ACACA acetyl-CoA carboxylase alpha multiple interactions EXP Quinacrine results in decreased activity of and results in increased phosphorylation of ACACA protein CTD PMID:35724837 NCBI chr17:37,084,992...37,406,836
Ensembl chr17:37,084,992...37,406,836
JBrowse link
G AGT angiotensinogen multiple interactions ISO Quinacrine inhibits the reaction [AGT protein results in increased metabolism of and results in increased abundance of Arachidonic Acid] CTD PMID:16257180 NCBI chr 1:230,702,523...230,745,583
Ensembl chr 1:230,690,776...230,745,576
JBrowse link
G BAX BCL2 associated X, apoptosis regulator increases response to substance
increases expression
multiple interactions
EXP BAX protein results in increased susceptibility to Quinacrine
Quinacrine results in increased expression of BAX mRNA
4-(4-fluorophenyl)-2-(4-hydroxyphenyl)-5-(4-pyridyl)imidazole inhibits the reaction [Quinacrine results in increased expression of BAX mRNA]; 4-(4-fluorophenyl)-2-(4-hydroxyphenyl)-5-(4-pyridyl)imidazole inhibits the reaction [Quinacrine results in increased expression of BAX protein]; BTRC protein inhibits the reaction [Quinacrine results in increased expression of BAX protein]; mithramycin A inhibits the reaction [Quinacrine results in increased expression of BAX mRNA]; mithramycin A inhibits the reaction [Quinacrine results in increased expression of BAX protein]; Quinacrine promotes the reaction [SP1 protein binds to BAX promoter]; Quinacrine results in increased expression of and affects the localization of BAX protein
CTD PMID:16177561 PMID:28867437 NCBI chr19:48,954,875...48,961,798
Ensembl chr19:48,954,815...48,961,798
JBrowse link
G BTRC beta-transducin repeat containing E3 ubiquitin protein ligase multiple interactions
decreases expression
EXP 4-(4-fluorophenyl)-2-(4-hydroxyphenyl)-5-(4-pyridyl)imidazole inhibits the reaction [Quinacrine results in decreased expression of BTRC protein]; BTRC protein inhibits the reaction [Quinacrine results in increased expression of BAX protein]; BTRC protein inhibits the reaction [Quinacrine results in increased expression of SP1 protein]; FOXP3 protein affects the reaction [Quinacrine results in decreased expression of BTRC protein]; MIR183 mRNA affects the reaction [Quinacrine results in decreased expression of BTRC protein]; Quinacrine results in decreased expression of and results in decreased stability of BTRC mRNA CTD PMID:28867437 NCBI chr10:101,354,048...101,557,313
Ensembl chr10:101,354,033...101,557,321
JBrowse link
G CASP3 caspase 3 increases cleavage
increases activity
multiple interactions
EXP Quinacrine results in increased cleavage of CASP3 protein
Quinacrine results in increased activity of CASP3 protein
GSK3B protein affects the reaction [Quinacrine results in increased activity of CASP3 protein]
CTD PMID:28720477 PMID:28867437 NCBI chr 4:184,627,696...184,649,447
Ensembl chr 4:184,627,696...184,650,062
JBrowse link
G CASP9 caspase 9 increases cleavage EXP Quinacrine results in increased cleavage of CASP9 protein CTD PMID:28867437 NCBI chr 1:15,491,401...15,524,912
Ensembl chr 1:15,490,832...15,526,534
JBrowse link
G CCND1 cyclin D1 multiple interactions
decreases expression
EXP GSK3B protein affects the reaction [Quinacrine results in decreased expression of CCND1 protein] CTD PMID:28720477 NCBI chr11:69,641,156...69,654,474
Ensembl chr11:69,641,156...69,654,474
JBrowse link
G CDKN1A cyclin dependent kinase inhibitor 1A decreases expression EXP Quinacrine results in decreased expression of CDKN1A mRNA CTD PMID:32910239 NCBI chr 6:36,676,463...36,687,332
Ensembl chr 6:36,676,460...36,687,337
JBrowse link
G CSNK1A1 casein kinase 1 alpha 1 increases expression
multiple interactions
EXP Quinacrine results in increased expression of CSNK1A1 protein
GSK3B protein affects the reaction [Quinacrine results in increased expression of CSNK1A1 protein]
CTD PMID:28720477 NCBI chr 5:149,492,982...149,551,439
Ensembl chr 5:149,492,982...149,551,471
JBrowse link
G CTNNB1 catenin beta 1 multiple interactions
decreases expression
EXP GSK3B protein affects the reaction [Quinacrine results in decreased expression of CTNNB1 protein] CTD PMID:28720477 NCBI chr 3:41,199,505...41,240,443
Ensembl chr 3:41,194,741...41,260,096
JBrowse link
G CYP1A1 cytochrome P450 family 1 subfamily A member 1 increases metabolic processing EXP CYP1A1 protein results in increased metabolism of Quinacrine CTD PMID:16581945 NCBI chr15:74,719,542...74,725,528
Ensembl chr15:74,719,542...74,725,536
JBrowse link
G CYP2E1 cytochrome P450 family 2 subfamily E member 1 multiple interactions
decreases expression
ISO Quinacrine binds to and results in decreased activity of CYP2E1 protein
Quinacrine results in decreased expression of CYP2E1 protein
CTD PMID:18754103 NCBI chr10:133,527,363...133,539,123
Ensembl chr10:133,520,406...133,561,220
JBrowse link
G CYP3A4 cytochrome P450 family 3 subfamily A member 4 increases metabolic processing EXP CYP3A4 protein results in increased metabolism of Quinacrine CTD PMID:16581945 NCBI chr 7:99,756,967...99,784,184
Ensembl chr 7:99,756,960...99,784,248
JBrowse link
G CYP3A5 cytochrome P450 family 3 subfamily A member 5 increases metabolic processing EXP CYP3A5 protein results in increased metabolism of Quinacrine CTD PMID:16581945 NCBI chr 7:99,648,194...99,679,996
Ensembl chr 7:99,648,194...99,679,996
JBrowse link
G FOXP3 forkhead box P3 multiple interactions
increases expression
EXP 4-(4-fluorophenyl)-2-(4-hydroxyphenyl)-5-(4-pyridyl)imidazole inhibits the reaction [Quinacrine results in increased expression of FOXP3 mRNA]; 4-(4-fluorophenyl)-2-(4-hydroxyphenyl)-5-(4-pyridyl)imidazole inhibits the reaction [Quinacrine results in increased expression of FOXP3 protein]; FOXP3 protein affects the reaction [Quinacrine results in decreased expression of BTRC protein]; FOXP3 protein affects the reaction [Quinacrine results in increased expression of MIR183 mRNA]; FOXP3 protein affects the reaction [Quinacrine results in increased expression of SP1 protein]
Quinacrine results in increased expression of FOXP3 mRNA; Quinacrine results in increased expression of FOXP3 protein
CTD PMID:28867437 NCBI chr  X:49,250,438...49,264,710
Ensembl chr  X:49,250,438...49,264,800
JBrowse link
G GLI1 GLI family zinc finger 1 decreases expression
multiple interactions
EXP Quinacrine results in decreased expression of GLI1 protein
GSK3B protein affects the reaction [Quinacrine results in decreased expression of GLI1 protein]
CTD PMID:28720477 NCBI chr12:57,459,785...57,472,268
Ensembl chr12:57,459,785...57,472,268
JBrowse link
G GSK3B glycogen synthase kinase 3 beta increases expression
multiple interactions
EXP Quinacrine results in increased expression of GSK3B mRNA
GSK3B protein affects the reaction [Quinacrine results in decreased expression of CCND1 protein]; GSK3B protein affects the reaction [Quinacrine results in decreased expression of CTNNB1 protein]; GSK3B protein affects the reaction [Quinacrine results in decreased expression of GLI1 protein]; GSK3B protein affects the reaction [Quinacrine results in decreased expression of MYC protein]; GSK3B protein affects the reaction [Quinacrine results in increased activity of CASP3 protein]; GSK3B protein affects the reaction [Quinacrine results in increased expression of CSNK1A1 protein]; Quinacrine results in increased expression of and results in decreased phosphorylation of GSK3B protein
CTD PMID:28720477 NCBI chr 3:119,821,321...120,094,447
Ensembl chr 3:119,821,321...120,094,994
JBrowse link
G IL1A interleukin 1 alpha multiple interactions ISO Quinacrine inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of IL1A mRNA] CTD PMID:8435107 NCBI chr 2:112,773,925...112,784,493
Ensembl chr 2:112,773,925...112,784,493
JBrowse link
G KCNH2 potassium voltage-gated channel subfamily H member 2 decreases activity EXP Quinacrine results in decreased activity of KCNH2 protein CTD PMID:28551711 NCBI chr 7:150,944,961...150,978,321
Ensembl chr 7:150,944,961...150,978,321
JBrowse link
G KDR kinase insert domain receptor decreases phosphorylation EXP Quinacrine results in decreased phosphorylation of KDR protein CTD PMID:35724837 NCBI chr 4:55,078,481...55,125,595
Ensembl chr 4:55,078,481...55,125,595
JBrowse link
G MAPK1 mitogen-activated protein kinase 1 multiple interactions
decreases phosphorylation
EXP 4-(4-fluorophenyl)-2-(4-hydroxyphenyl)-5-(4-pyridyl)imidazole inhibits the reaction [Quinacrine results in decreased phosphorylation of MAPK1 protein]; Acetylcysteine inhibits the reaction [Quinacrine results in decreased phosphorylation of MAPK1 protein] CTD PMID:28867437 NCBI chr22:21,759,657...21,867,680
Ensembl chr22:21,759,657...21,867,680
JBrowse link
G MAPK3 mitogen-activated protein kinase 3 multiple interactions
decreases phosphorylation
EXP 4-(4-fluorophenyl)-2-(4-hydroxyphenyl)-5-(4-pyridyl)imidazole inhibits the reaction [Quinacrine results in decreased phosphorylation of MAPK3 protein]; Acetylcysteine inhibits the reaction [Quinacrine results in decreased phosphorylation of MAPK3 protein] CTD PMID:28867437 NCBI chr16:30,114,105...30,123,220
Ensembl chr16:30,114,105...30,123,506
JBrowse link
G MIR183 microRNA 183 increases expression
multiple interactions
EXP Quinacrine results in increased expression of MIR183 mRNA
FOXP3 protein affects the reaction [Quinacrine results in increased expression of MIR183 mRNA]; MIR183 mRNA affects the reaction [Quinacrine results in decreased expression of BTRC protein]; MIR183 mRNA affects the reaction [Quinacrine results in increased expression of SP1 protein]
CTD PMID:28867437 NCBI chr 7:129,774,905...129,775,014
Ensembl chr 7:129,774,905...129,775,014
JBrowse link
G MYC MYC proto-oncogene, bHLH transcription factor decreases expression
multiple interactions
EXP Quinacrine results in decreased expression of MYC protein
GSK3B protein affects the reaction [Quinacrine results in decreased expression of MYC protein]
CTD PMID:28720477 NCBI chr 8:127,735,434...127,742,951
Ensembl chr 8:127,735,434...127,742,951
JBrowse link
G NQO2 N-ribosyldihydronicotinamide:quinone dehydrogenase 2 multiple interactions EXP Quinacrine binds to and results in decreased activity of NQO2 protein CTD PMID:15078100 NCBI chr 6:2,999,894...3,019,755
Ensembl chr 6:2,987,987...3,019,755
JBrowse link
G OTC ornithine transcarbamylase multiple interactions ISO Quinacrine inhibits the reaction [PRL protein results in increased activity of OTC protein]; Quinacrine inhibits the reaction [Tetradecanoylphorbol Acetate results in increased activity of OTC protein] CTD PMID:3097147 NCBI chr  X:38,327,684...38,422,928
Ensembl chr  X:38,352,586...38,421,446
JBrowse link
G PARP1 poly(ADP-ribose) polymerase 1 increases cleavage EXP Quinacrine results in increased cleavage of PARP1 protein CTD PMID:28867437 NCBI chr 1:226,360,691...226,408,093
Ensembl chr 1:226,360,210...226,408,154
JBrowse link
G PLCG1 phospholipase C gamma 1 decreases phosphorylation EXP Quinacrine results in decreased phosphorylation of PLCG1 protein CTD PMID:35724837 NCBI chr20:41,137,543...41,177,626
Ensembl chr20:41,136,960...41,196,801
JBrowse link
G PRL prolactin multiple interactions ISO Quinacrine inhibits the reaction [PRL protein results in increased activity of OTC protein] CTD PMID:3097147 NCBI chr 6:22,287,246...22,302,835
Ensembl chr 6:22,287,244...22,302,826
JBrowse link
G PTK2 protein tyrosine kinase 2 decreases phosphorylation EXP Quinacrine results in decreased phosphorylation of PTK2 protein CTD PMID:35724837 NCBI chr 8:140,657,900...141,002,079
Ensembl chr 8:140,657,900...141,002,216
JBrowse link
G SP1 Sp1 transcription factor multiple interactions EXP 4-(4-fluorophenyl)-2-(4-hydroxyphenyl)-5-(4-pyridyl)imidazole inhibits the reaction [Quinacrine results in increased expression of SP1 protein]; BTRC protein inhibits the reaction [Quinacrine results in increased expression of SP1 protein]; FOXP3 protein affects the reaction [Quinacrine results in increased expression of SP1 protein]; MIR183 mRNA affects the reaction [Quinacrine results in increased expression of SP1 protein]; Quinacrine promotes the reaction [SP1 protein binds to BAX promoter]; Quinacrine results in increased expression of and results in increased stability of SP1 protein CTD PMID:28867437 NCBI chr12:53,380,176...53,416,446
Ensembl chr12:53,380,176...53,416,446
JBrowse link
G TLR3 toll like receptor 3 multiple interactions EXP Quinacrine inhibits the reaction [Poly I-C results in increased activity of TLR3 protein] CTD PMID:21398612 NCBI chr 4:186,069,156...186,088,073
Ensembl chr 4:186,068,911...186,088,073
JBrowse link
G TP53 tumor protein p53 increases activity
affects activity
multiple interactions
EXP Quinacrine results in increased activity of TP53 protein
Quinacrine affects the activity of TP53 protein
Quinacrine results in increased stability of and results in increased activity of TP53 protein
CTD PMID:12082016 PMID:16177561 PMID:35435491 NCBI chr17:7,668,421...7,687,490
Ensembl chr17:7,661,779...7,687,538
JBrowse link
thiethylperazine term browser
Symbol Object Name Qualifiers Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
G ABCC1 ATP binding cassette subfamily C member 1 (ABCC1 blood group) multiple interactions ISO [Thiethylperazine results in increased activity of ABCC1 protein] which results in increased export of APP protein CTD PMID:21881209 NCBI chr16:15,949,143...16,143,053
Ensembl chr16:15,949,138...16,143,257
JBrowse link
G APP amyloid beta precursor protein multiple interactions ISO [Thiethylperazine results in increased activity of ABCC1 protein] which results in increased export of APP protein CTD PMID:21881209 NCBI chr21:25,880,550...26,171,128
Ensembl chr21:25,880,535...26,171,128
JBrowse link
triflupromazine term browser
Symbol Object Name Qualifiers Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
G KCNH2 potassium voltage-gated channel subfamily H member 2 decreases activity EXP Triflupromazine results in decreased activity of KCNH2 protein CTD PMID:28551711 NCBI chr 7:150,944,961...150,978,321
Ensembl chr 7:150,944,961...150,978,321
JBrowse link
trimipramine term browser
Symbol Object Name Qualifiers Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
G SLC22A2 solute carrier family 22 member 2 multiple interactions EXP Trimipramine inhibits the reaction [SLC22A2 protein results in increased uptake of 4-(4-dimethylaminostyryl)-1-methylpyridinium] CTD PMID:21599003 NCBI chr 6:160,216,755...160,258,821
Ensembl chr 6:160,171,061...160,277,638
JBrowse link

Term paths to the root
Path 1
Term Annotations click to browse term
  CHEBI ontology 26040
    chemical entity 26019
      molecular entity 25997
        mancude ring 11711
          organic mancude parent 11711
            mancude organic heterocyclic parent 11711
              mancude organic heterotricyclic parent 385
                1H-imidazo[4,5-c]quinoline 0
                5H-dibenzo[b,f]azepine + 134
                acridine + 34
                benzo[de]isoquinoline + 0
                benzo[g]pteridine 0
                beta-carboline + 24
                carbazole + 1
                dibenzofuran + 39
                dibenzothiophene + 4
                imidazo[2,1-i]purine + 2
                oxanthrene 1
                perimidine + 0
                phenanthridine + 23
                phenanthroline + 168
                phenazine + 0
                phenothiazine + 35
                thianthrene + 0
                thioxanthene + 0
                tri-s-triazine 0
                xanthene + 0
Path 2
Term Annotations click to browse term
  CHEBI ontology 26040
    subatomic particle 26015
      composite particle 26015
        hadron 26015
          baryon 26015
            nucleon 26015
              atomic nucleus 26015
                atom 26015
                  main group element atom 25840
                    p-block element atom 25840
                      carbon group element atom 25441
                        carbon atom 25399
                          organic molecular entity 25399
                            organic molecule 25228
                              organic cyclic compound 24279
                                organic heterocyclic compound 22322
                                  organic heteropolycyclic compound 21309
                                    organic heterotricyclic compound 15987
                                      mancude organic heterotricyclic parent 385
                                        1H-imidazo[4,5-c]quinoline 0
                                        5H-dibenzo[b,f]azepine + 134
                                        acridine + 34
                                        benzo[de]isoquinoline + 0
                                        benzo[g]pteridine 0
                                        beta-carboline + 24
                                        carbazole + 1
                                        dibenzofuran + 39
                                        dibenzothiophene + 4
                                        imidazo[2,1-i]purine + 2
                                        oxanthrene 1
                                        perimidine + 0
                                        phenanthridine + 23
                                        phenanthroline + 168
                                        phenazine + 0
                                        phenothiazine + 35
                                        thianthrene + 0
                                        thioxanthene + 0
                                        tri-s-triazine 0
                                        xanthene + 0
paths to the root